Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 538 articles:
HTML format



Single Articles


    January 2022
  1. BAJOS N, Spire A, Silberzan L
    The social specificities of hostility toward vaccination against Covid-19 in France.
    PLoS One. 2022;17:e0262192.
    PubMed     Abstract available


  2. PATEL SM, Shaik-Dasthagirisaheb YB, Congdon M, Young RR, et al
    Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.
    PLoS One. 2022;17:e0262225.
    PubMed     Abstract available


  3. NG OMBE H, Simuyandi M, Mwaba J, Luchen CC, et al
    Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol) in adults residing in Lukanga Swamps of Zambia.
    PLoS One. 2022;17:e0262239.
    PubMed     Abstract available


  4. RINTA-KOKKO H, Palmu AA, Ruokokoski E, Nieminen H, et al
    Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial.
    PLoS One. 2022;17:e0261750.
    PubMed     Abstract available


  5. YOUNG-XU Y, Smith J, Nealon J, Mahmud SM, et al
    Influenza vaccine in chronic obstructive pulmonary disease among elderly male veterans.
    PLoS One. 2022;17:e0262072.
    PubMed     Abstract available


  6. LEE C, Holroyd TA, Gur-Arie R, Sauer M, et al
    COVID-19 vaccine acceptance among Bangladeshi adults: Understanding predictors of vaccine intention to inform vaccine policy.
    PLoS One. 2022;17:e0261929.
    PubMed     Abstract available


  7. AKTHER T, Nur T
    A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.
    PLoS One. 2022;17:e0261869.
    PubMed     Abstract available


  8. GHADDAR A, Khandaqji S, Awad Z, Kansoun R, et al
    Conspiracy beliefs and vaccination intent for COVID-19 in an infodemic.
    PLoS One. 2022;17:e0261559.
    PubMed     Abstract available


  9. SIEWE N, Friedman A
    Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.
    PLoS One. 2022;17:e0262453.
    PubMed     Abstract available


  10. TEERAWATTANANON Y, Anothaisintawee T, Pheerapanyawaranun C, Botwright S, et al
    A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.
    PLoS One. 2022;17:e0261930.
    PubMed     Abstract available


  11. SEO J, Lim J
    The impact of free vaccination policies under the Korean Influenza National Immunization Program: Trends in influenza vaccination rates in South Korea from 2010 to 2019.
    PLoS One. 2022;17:e0262594.
    PubMed     Abstract available


  12. STRICKLAND JC, Reed DD, Hursh SR, Schwartz LP, et al
    Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic.
    PLoS One. 2022;17:e0258828.
    PubMed     Abstract available


  13. WISNEWSKI AV, Liu J, Lucas C, Klein J, et al
    Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses.
    PLoS One. 2022;17:e0262657.
    PubMed     Abstract available


  14. YOKOTA H, Hayashi H, Hanaguri J, Yamagami S, et al
    Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes.
    PLoS One. 2022;17:e0262568.
    PubMed     Abstract available


  15. DIRIRSA K, Makuria M, Mulu E, Deriba BS, et al
    Assessment of vaccination timeliness and associated factors among children in Toke Kutaye district, central Ethiopia: A Mixed study.
    PLoS One. 2022;17:e0262320.
    PubMed     Abstract available


  16. RAUT S, Apte A, Srinivasan M, Dudeja N, et al
    Determinants of maternal influenza vaccination in the context of low- and middle-income countries: A systematic review.
    PLoS One. 2022;17:e0262871.
    PubMed     Abstract available


  17. MOSE A, Haile K, Timerga A
    COVID-19 vaccine hesitancy among medical and health science students attending Wolkite University in Ethiopia.
    PLoS One. 2022;17:e0263081.
    PubMed     Abstract available


  18. RAMATILLAH DL, Gan SH, Pratiwy I, Syed Sulaiman SA, et al
    Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination.
    PLoS One. 2022;17:e0262438.
    PubMed     Abstract available


  19. LIAO CC, Tai YH, Yeh CC, Hsu YH, et al
    Effect of influenza vaccination on the outcomes of hospitalization for kidney disease in a geriatric population: A propensity-score matched study.
    PLoS One. 2022;17:e0262420.
    PubMed     Abstract available


  20. AMINUDDIN F, Zaimi NA, Mohd Nor Sham Kunusagaran MSJ, Bahari MS, et al
    Cost-effectiveness and budget impact analysis of PPV23 vaccination for the Malaysian Hajj pilgrims.
    PLoS One. 2022;17:e0262949.
    PubMed     Abstract available


  21. BELL S, Clarke RM, Ismail SA, Ojo-Aromokudu O, et al
    COVID-19 vaccination beliefs, attitudes, and behaviours among health and social care workers in the UK: A mixed-methods study.
    PLoS One. 2022;17:e0260949.
    PubMed     Abstract available


  22. NERY N JR, Ticona JPA, Cardoso CW, Prates APPB, et al
    COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
    PLoS One. 2022;17:e0262649.
    PubMed     Abstract available


  23. NISAR MI, Jehan F, Shahid S, Ahmed S, et al
    Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan.
    PLoS One. 2022;17:e0262466.
    PubMed     Abstract available


  24. OCAN M, Acheng F, Otike C, Beinomugisha J, et al
    Antibody levels and protection after Hepatitis B vaccine in adult vaccinated healthcare workers in northern Uganda.
    PLoS One. 2022;17:e0262126.
    PubMed     Abstract available


  25. KORANG SK, von Rohden E, Veroniki AA, Ong G, et al
    Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
    PLoS One. 2022;17:e0260733.
    PubMed     Abstract available


  26. OHMURA H
    Analysis of social combinations of COVID-19 vaccination: Evidence from a conjoint analysis.
    PLoS One. 2022;17:e0261426.
    PubMed     Abstract available


  27. CHEN PY, Chuang PN, Chiang CH, Chang HH, et al
    Impact of Coronavirus Infectious Disease (COVID-19) pandemic on willingness of immunization-A community-based questionnaire study.
    PLoS One. 2022;17:e0262660.
    PubMed     Abstract available


  28. TLALE LB, Gabaitiri L, Totolo LK, Smith G, et al
    Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    PLoS One. 2022;17:e0263375.
    PubMed     Abstract available


  29. PETROVIC V, Vukovic V, Patic A, Markovic M, et al
    Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.
    PLoS One. 2022;17:e0263468.
    PubMed     Abstract available


  30. BEARTH A, Berthold A, Siegrist M
    People's perceptions of, willingness-to-take preventive remedies and their willingness-to-vaccinate during times of heightened health threats.
    PLoS One. 2022;17:e0263351.
    PubMed     Abstract available


  31. VOIGT A, Omholt S, Almaas E
    Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    PLoS One. 2022;17:e0263155.
    PubMed     Abstract available


  32. PRATAMA NR, Wafa IA, Budi DS, Putra M, et al
    mRNA Covid-19 vaccines in pregnancy: A systematic review.
    PLoS One. 2022;17:e0261350.
    PubMed     Abstract available


  33. RONCHINI C, Gandini S, Pasqualato S, Mazzarella L, et al
    Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs.
    PLoS One. 2022;17:e0263014.
    PubMed     Abstract available


  34. MEMIRIE ST, Yigezu A, Zewdie SA, Mirkuzie AH, et al
    Hospitalization costs for COVID-19 in Ethiopia: Empirical data and analysis from Addis Ababa's largest dedicated treatment center.
    PLoS One. 2022;17:e0260930.
    PubMed     Abstract available


  35. JANOWSKI AB, Polgreen PM, Beekmann SE, Newland JG, et al
    Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey.
    PLoS One. 2022;17:e0263767.
    PubMed     Abstract available


  36. MAOR Y, Caspi S
    Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population.
    PLoS One. 2022;17:e0255495.
    PubMed     Abstract available


  37. HOSSIAN M, Khan MAS, Nazir A, Nabi MH, et al
    Factors affecting intention to take COVID-19 vaccine among Pakistani University Students.
    PLoS One. 2022;17:e0262305.
    PubMed     Abstract available


  38. DAVIS B, Krautmann M, Leroueil PR
    A method for estimating the impact of new vaccine technologies on vaccination coverage rates.
    PLoS One. 2022;17:e0263612.
    PubMed     Abstract available


  39. BASSI J, Giannini O, Silacci-Fregni C, Pertusini L, et al
    Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.
    PLoS One. 2022;17:e0263328.
    PubMed     Abstract available


  40. ALHENDYANI F, Jolly K, Jones LL
    Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis.
    PLoS One. 2022;17:e0263234.
    PubMed     Abstract available


  41. MONSTED B, Lehmann S
    Characterizing polarization in online vaccine discourse-A large-scale study.
    PLoS One. 2022;17:e0263746.
    PubMed     Abstract available


  42. SINGH K, Lima G, Cha M, Cha C, et al
    Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic.
    PLoS One. 2022;17:e0263381.
    PubMed     Abstract available


  43. JUNG BK, An YH, Jang JJ, Jeon JH, et al
    The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.
    PLoS One. 2022;17:e0263684.
    PubMed     Abstract available


  44. EGLOFF C, Couffignal C, Cordier AG, Deruelle P, et al
    Pregnant women's perceptions of the COVID-19 vaccine: A French survey.
    PLoS One. 2022;17:e0263512.
    PubMed     Abstract available


  45. ZHOU L, Ampon-Wireko S, Xu X, Quansah PE, et al
    Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership.
    PLoS One. 2022;17:e0263610.
    PubMed     Abstract available


  46. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    Infection and vaccination status of COVID-19 among healthcare professionals in academic platform: Prevision vs. reality of Bangladesh context.
    PLoS One. 2022;17:e0263078.
    PubMed     Abstract available


  47. LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
    Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults.
    PLoS One. 2022;17:e0264062.
    PubMed     Abstract available


  48. JAMISON AF, McCormick BJJ, Hussain E, Thomas ED, et al
    Determinants of vaccine coverage and timeliness in a northern Pakistani village.
    PLoS One. 2022;17:e0263712.
    PubMed     Abstract available


  49. ROBERTS HA, Clark DA, Kalina C, Sherman C, et al
    To vax or not to vax: Predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability.
    PLoS One. 2022;17:e0264019.
    PubMed     Abstract available


  50. KANE PB, Moyer H, MacPherson A, Papenburg J, et al
    Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.
    PLoS One. 2022;17:e0262740.
    PubMed     Abstract available


  51. DIEHL C, Hunkler C
    Vaccination-related attitudes and behavior across birth cohorts: Evidence from Germany.
    PLoS One. 2022;17:e0263871.
    PubMed     Abstract available


  52. BUDZIAR W, Gembara K, Harhala M, Szymczak A, et al
    Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    PLoS One. 2022;17:e0253638.
    PubMed     Abstract available


  53. ENYEW EB, Tareke AA
    Vaccination status and factors associated among children age 12-23 months in Ethiopia, based on 2016 EDHS: Logit based multinomial logistic regression analysis.
    PLoS One. 2022;17:e0264004.
    PubMed     Abstract available


  54. ADEDEJI-ADENOLA H, Olugbake OA, Adeosun SA
    Factors influencing COVID-19 vaccine uptake among adults in Nigeria.
    PLoS One. 2022;17:e0264371.
    PubMed     Abstract available


  55. MAMUTI S, Tabu C, Marete I, Opili D, et al
    Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    PLoS One. 2022;17:e0263780.
    PubMed     Abstract available


  56. YOUSSEF D, Abou-Abbas L, Berry A, Youssef J, et al
    Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model.
    PLoS One. 2022;17:e0264128.
    PubMed     Abstract available


  57. BSOUL EA, Loomer PM
    COVID-19 vaccination experience among United States dental professionals and students: Safety, confidence, concerns, and side effects.
    PLoS One. 2022;17:e0264323.
    PubMed     Abstract available


  58. BONHOMME ME, Bonhomme CJ, Strelow L, Chaudhari A, et al
    Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    PLoS One. 2022;17:e0262922.
    PubMed     Abstract available


  59. LI H, Ren H, Zhou Y, Zhang Y, et al
    HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice.
    PLoS One. 2022;17:e0262231.
    PubMed     Abstract available


  60. ACKHTER MM, Shahid ASMSB, Ahmed T, Palit P, et al
    Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guerin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.
    PLoS One. 2022;17:e0262391.
    PubMed     Abstract available


  61. STRUPAT C, Shigute Z, Bedi AS, Rieger M, et al
    Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    PLoS One. 2022;17:e0264633.
    PubMed     Abstract available


  62. ROMERO-IBARGUENGOITIA ME, Rivera-Salinas D, Hernandez-Ruiz YG, Armendariz-Vazquez AG, et al
    Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel.
    PLoS One. 2022;17:e0263942.
    PubMed     Abstract available


  63. PAVIC Z, Suljok A
    Vaccination conspiracy beliefs among social science & humanities and STEM educated people-An analysis of the mediation paths.
    PLoS One. 2022;17:e0264722.
    PubMed     Abstract available


  64. FOJNICA A, Osmanovic A, Duzic N, Fejzic A, et al
    COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina.
    PLoS One. 2022;17:e0264754.
    PubMed     Abstract available


  65. SANDOR J, Vincze F, Shrikant ML, Korosi L, et al
    COVID-19 vaccination coverage in deprived populations living in segregated colonies: A nationwide cross-sectional study in Hungary.
    PLoS One. 2022;17:e0264363.
    PubMed     Abstract available


  66. TSUNETSUGU-YOKOTA Y, Ito S, Adachi Y, Onodera T, et al
    Saliva as a useful tool for evaluating upper mucosal antibody response to influenza.
    PLoS One. 2022;17:e0263419.
    PubMed     Abstract available


  67. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    PubMed     Abstract available


  68. FREUDENBERGER CATANZARO KC, Lahmers KK, Allen IC, Inzana TJ, et al
    Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
    PLoS One. 2022;17:e0259807.
    PubMed     Abstract available


  69. GEORGE CE, Inbaraj LR, Rajukutty S, Joan RF, et al
    Seroprevalence of COVID-19 infection among vaccine naive population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
    PLoS One. 2022;17:e0265236.
    PubMed     Abstract available


  70. CHUKWU CA, Mahmood K, Elmakki S, Gorton J, et al
    Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
    PLoS One. 2022;17:e0265130.
    PubMed     Abstract available


  71. GREYLING T, Rossouw S
    Positive attitudes towards COVID-19 vaccines: A cross-country analysis.
    PLoS One. 2022;17:e0264994.
    PubMed     Abstract available


  72. TOLOSSA T, Wakuma B, Turi E, Mulisa D, et al
    Attitude of health professionals towards COVID-19 vaccination and associated factors among health professionals, Western Ethiopia: A cross-sectional survey.
    PLoS One. 2022;17:e0265061.
    PubMed     Abstract available


  73. KUGELER KJ, Williamson J, Curns AT, Healy JM, et al
    Estimating the number of symptomatic SARS-CoV-2 infections among vaccinated individuals in the United States-January-July, 2021.
    PLoS One. 2022;17:e0264179.
    PubMed     Abstract available


  74. ORTIZ-PAREDES D, Varsaneux O, Worthington J, Park H, et al
    Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.
    PLoS One. 2022;17:e0264145.
    PubMed     Abstract available


  75. TZOU PL, Tao K, Pond SLK, Shafer RW, et al
    Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons.
    PLoS One. 2022;17:e0261045.
    PubMed     Abstract available


  76. ROCHA FILHO TM, Mendes JFF, Murari TB, Nascimento Filho AS, et al
    Optimization of COVID-19 vaccination and the role of individuals with a high number of contacts: A model based approach.
    PLoS One. 2022;17:e0262433.
    PubMed     Abstract available


  77. HABIBZADEH F, Chumakov K, Sajadi MM, Yadollahie M, et al
    Use of oral polio vaccine and the incidence of COVID-19 in the world.
    PLoS One. 2022;17:e0265562.
    PubMed     Abstract available


  78. XIAO S, Nayak B, Samuel A, Paldurai A, et al
    Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain.
    PLoS One. 2022;17:e0265578.
    PubMed     Abstract available


  79. HAMILTON K, Hagger MS
    The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation.
    PLoS One. 2022;17:e0264784.
    PubMed     Abstract available


  80. BEG BM, Hussain T, Ahmad M, Areej S, et al
    Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.
    PLoS One. 2022;17:e0266028.
    PubMed     Abstract available


  81. REINHARDT B, Taylor R, Dawkins C, Banks T, et al
    The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster.
    PLoS One. 2022;17:e0265813.
    PubMed     Abstract available


  82. SAJID M, Marriam S, Mukhtar H, Sohail S, et al
    Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2.
    PLoS One. 2022;17:e0264700.
    PubMed     Abstract available


  83. ROY DN, Biswas M, Islam E, Azam MS, et al
    Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review.
    PLoS One. 2022;17:e0265496.
    PubMed     Abstract available


  84. DHAOUADI S, Kharroubi G, Cherif A, Cherif I, et al
    Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia.
    PLoS One. 2022;17:e0265390.
    PubMed     Abstract available


  85. SPRENGER R, Hackl D, Kossack N, Schiffner-Rohe J, et al
    Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
    PLoS One. 2022;17:e0265433.
    PubMed     Abstract available


  86. PURSELL T, Spencer Clinton JL, Tan J, Peng R, et al
    Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.
    PLoS One. 2022;17:e0265424.
    PubMed     Abstract available


  87. HIMBERT S, Gastaldo IP, Ahmed R, Pomier KM, et al
    Erythro-VLPs: Anchoring SARS-CoV-2 spike proteins in erythrocyte liposomes.
    PLoS One. 2022;17:e0263671.
    PubMed     Abstract available


  88. HARTMANN W, Brunn ML, Stetter N, Gabriel G, et al
    Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice.
    PLoS One. 2022;17:e0266456.
    PubMed     Abstract available


  89. CHRISTODOULOU J, Fehrenbacher AE, Shaw EH, Vincent EM, et al
    COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV.
    PLoS One. 2022;17:e0266321.
    PubMed     Abstract available


  90. NEWMAN PA, Reid L, Tepjan S, Fantus S, et al
    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review.
    PLoS One. 2022;17:e0266120.
    PubMed     Abstract available


  91. AL-DAHSHAN A, Selim N, Al-Kubaisi N, Mahfoud Z, et al
    Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.
    PLoS One. 2022;17:e0265953.
    PubMed     Abstract available


  92. KREPS S, Kriner DL
    Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States.
    PLoS One. 2022;17:e0265011.
    PubMed     Abstract available


  93. THIRUMURTHY H, Milkman KL, Volpp KG, Buttenheim AM, et al
    Association between statewide financial incentive programs and COVID-19 vaccination rates.
    PLoS One. 2022;17:e0263425.
    PubMed     Abstract available


  94. NOURANI L, Abouie Mehrizi A, Zakeri S, Djadid ND, et al
    Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
    PLoS One. 2022;17:e0266067.
    PubMed     Abstract available


  95. HAJEK A, Konig HH
    Level and correlates of empathy and altruism during the Covid-19 pandemic. Evidence from a representative survey in Germany.
    PLoS One. 2022;17:e0265544.
    PubMed     Abstract available


  96. GRASO M
    The new normal: Covid-19 risk perceptions and support for continuing restrictions past vaccinations.
    PLoS One. 2022;17:e0266602.
    PubMed     Abstract available


  97. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    PubMed     Abstract available


  98. RAJA SM, Osman ME, Musa AO, Hussien AA, et al
    COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.
    PLoS One. 2022;17:e0266670.
    PubMed     Abstract available


  99. FISKE A, Schonweitz F, Eichinger J, Zimmermann B, et al
    The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    PLoS One. 2022;17:e0266659.
    PubMed     Abstract available


  100. HASSOUNEH L, Dunsiger S
    The impact of mental distress on influenza vaccine coverage.
    PLoS One. 2022;17:e0266692.
    PubMed     Abstract available


  101. KAINE G, Wright V, Greenhalgh S
    Predicting willingness to be vaccinated for Covid-19: Evidence from New Zealand.
    PLoS One. 2022;17:e0266485.
    PubMed     Abstract available


  102. OCHWEDO KO, Onyango SA, Omondi CJ, Orondo PW, et al
    Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.
    PLoS One. 2022;17:e0266394.
    PubMed     Abstract available


  103. NAVAZI F, Yuan Y, Archer N
    The effect of the Ontario stay-at-home order on Covid-19 third wave infections including vaccination considerations: An interrupted time series analysis.
    PLoS One. 2022;17:e0265549.
    PubMed     Abstract available


  104. JENSEN UT, Ayers S, Koskan AM
    Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions.
    PLoS One. 2022;17:e0265736.
    PubMed     Abstract available


  105. REN Z, Nishimura M, Tjan LH, Furukawa K, et al
    Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.
    PLoS One. 2022;17:e0266270.
    PubMed     Abstract available


  106. SHARMA R, Anand A
    The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines.
    PLoS One. 2022;17:e0266271.
    PubMed     Abstract available


  107. ALHATIM N, Al-Bashaireh AM, Alqudah O
    Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia.
    PLoS One. 2022;17:e0266440.
    PubMed     Abstract available


  108. KIHL P, Krych L, Deng L, Hansen LH, et al
    Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.
    PLoS One. 2022;17:e0266719.
    PubMed     Abstract available


  109. MEYERHARDT JA, Yue H, Nowak RP, Brais L, et al
    Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center.
    PLoS One. 2022;17:e0266791.
    PubMed     Abstract available


  110. RAHIMI BA, Ishaq N, Mudaser GM, Taylor WR, et al
    Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.
    PLoS One. 2022;17:e0265487.
    PubMed     Abstract available


  111. SEDEGAH M, Porter C, Hollingdale MR, Ganeshan H, et al
    CHARM: COVID-19 Health Action Response for Marines-Association of antigen-specific interferon-gamma and IL2 responses with asymptomatic and symptomatic infections after a positive qPCR SARS-CoV-2 test.
    PLoS One. 2022;17:e0266691.
    PubMed     Abstract available


  112. SARGENT RH, Laurie S, Moncada L, Weakland LF, et al
    Masks, money, and mandates: A national survey on efforts to increase COVID-19 vaccination intentions in the United States.
    PLoS One. 2022;17:e0267154.
    PubMed     Abstract available


  113. SAITO Y
    The role of vaccination in a model of asset pricing during a pandemic.
    PLoS One. 2022;17:e0266511.
    PubMed     Abstract available


  114. RABIL MJ, Tunc S, Bish DR, Bish EK, et al
    Benefits of integrated screening and vaccination for infection control.
    PLoS One. 2022;17:e0267388.
    PubMed     Abstract available


  115. MUNDAGOWA PT, Tozivepi SN, Chiyaka ET, Mukora-Mutseyekwa F, et al
    Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey.
    PLoS One. 2022;17:e0266724.
    PubMed     Abstract available


  116. BARMPOUNAKIS P, Demiris N, Kontoyiannis I, Pavlakis GN, et al
    Evaluating the effects of second-dose vaccine-delay policies in European countries: A simulation study based on data from Greece.
    PLoS One. 2022;17:e0263977.
    PubMed     Abstract available


  117. SHUKLA A, Welch K, Villa A
    Assessment of the willingness of dentists in the state of Indiana to administer vaccines.
    PLoS One. 2022;17:e0267167.
    PubMed     Abstract available


  118. LIN GSS, Lee HY, Leong JZ, Sulaiman MM, et al
    COVID-19 vaccination acceptance among dental students and dental practitioners: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0267354.
    PubMed     Abstract available


  119. ABED ELHADI SHAHBARI N, Gesser-Edelsburg A, Davidovitch N, Brammli-Greenberg S, et al
    Risk perceptions regarding inclusion of seasonal influenza vaccinations in the school immunization program in Israel: Arab vs. Jewish mothers.
    PLoS One. 2022;17:e0267279.
    PubMed     Abstract available


  120. CHAM J, Pandey AC, New J, Huynh T, et al
    6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    PLoS One. 2022;17:e0266781.
    PubMed     Abstract available


  121. GAULTIER GN, Nix EB, Thorgrimson J, Boreham D, et al
    Naturally acquired antibodies against 7 Streptococcus pneumoniae serotypes in Indigenous and non-Indigenous adults.
    PLoS One. 2022;17:e0267051.
    PubMed     Abstract available


  122. ANASTASSOPOULOU C, Antoni D, Manoussopoulos Y, Stefanou P, et al
    Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods.
    PLoS One. 2022;17:e0266958.
    PubMed     Abstract available


  123. JIAMSIRI S, Rhee C, Ahn HS, Poudyal N, et al
    A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX(R)) in female school students in Thailand.
    PLoS One. 2022;17:e0267294.
    PubMed     Abstract available


  124. BUCZEL M, Szyszka PD, Siwiak A, Szpitalak M, et al
    Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
    PLoS One. 2022;17:e0267463.
    PubMed     Abstract available


  125. RIGHOLT CH, Willows K, Kliewer EV, Mahmud SM, et al
    Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    PLoS One. 2022;17:e0267646.
    PubMed     Abstract available


  126. WIGGEN TD, Bohn B, Ulrich AK, Stovitz SD, et al
    SARS-CoV-2 seroprevalence among healthcare workers.
    PLoS One. 2022;17:e0266410.
    PubMed     Abstract available


  127. RICHARDSON JR, Gotz R, Mayr V, Lohse MJ, et al
    SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
    PLoS One. 2022;17:e0266701.
    PubMed     Abstract available


  128. CHANSAENROJ J, Yorsaeng R, Puenpa J, Wanlapakorn N, et al
    Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    PLoS One. 2022;17:e0267102.
    PubMed     Abstract available


  129. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    PubMed     Abstract available


  130. HONG H, Malfeld S, Smit S, Makhathini L, et al
    A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.
    PLoS One. 2022;17:e0265870.
    PubMed     Abstract available


  131. ASSI S, Arafat B, Abbas I, Evans K, et al
    Evaluation of portable near-infrared spectroscopy for authentication of mRNA based COVID-19 vaccines.
    PLoS One. 2022;17:e0267214.
    PubMed     Abstract available


  132. STOCKLI S, Spalti AK, Phillips J, Stoeckel F, et al
    Which vaccine attributes foster vaccine uptake? A cross-country conjoint experiment.
    PLoS One. 2022;17:e0266003.
    PubMed     Abstract available


  133. DONG L, Bogart LM, Gandhi P, Aboagye JB, et al
    A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake.
    PLoS One. 2022;17:e0268020.
    PubMed     Abstract available


  134. BICHER M, Rippinger C, Zechmeister M, Jahn B, et al
    An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply.
    PLoS One. 2022;17:e0265957.
    PubMed     Abstract available


  135. FLOREA A, Sy LS, Luo Y, Qian L, et al
    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.
    PLoS One. 2022;17:e0267824.
    PubMed     Abstract available


  136. STOTO MA, Schlageter S, Kraemer JD
    COVID-19 mortality in the United States: It's been two Americas from the start.
    PLoS One. 2022;17:e0265053.
    PubMed     Abstract available


  137. HONSKUS M, Okonji Z, Musilek M, Krizova P, et al
    Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-2018.
    PLoS One. 2022;17:e0265066.
    PubMed     Abstract available


  138. OLU-ABIODUN O, Abiodun O, Okafor N
    COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    PLoS One. 2022;17:e0267691.
    PubMed     Abstract available


  139. FREUND O, Tau L, Weiss TE, Zornitzki L, et al
    Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era.
    PLoS One. 2022;17:e0268050.
    PubMed     Abstract available


  140. FARIA DE CARVALHO R, de Siqueira Penna Quintaes L, de Cassia de Souza Su T, Mitiko Kobayashi L, et al
    Short communication: Feasibility of dengue vaccine to infect different human cell lines: An alternative potency test using HEK293T cells.
    PLoS One. 2022;17:e0267653.
    PubMed     Abstract available


  141. HIJANO DR, Hoffman JM, Tang L, Schultz-Cherry SL, et al
    An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic.
    PLoS One. 2022;17:e0268237.
    PubMed     Abstract available


  142. OKUNLOLA OA, Oyeyemi OT
    Malaria transmission in Africa: Its relationship with yellow fever and measles.
    PLoS One. 2022;17:e0268080.
    PubMed     Abstract available


  143. MURUGESAN M, Mathews P, Paul H, Karthik R, et al
    Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India.
    PLoS One. 2022;17:e0268797.
    PubMed     Abstract available


  144. SSEKAMATTE T, Isunju JB, Mutyoba JN, Tetui M, et al
    Predictors of Hepatitis B screening and vaccination status of young psychoactive substance users in informal settlements in Kampala, Uganda.
    PLoS One. 2022;17:e0267953.
    PubMed     Abstract available


  145. DAZA-TORRES ML, Garcia YE, Schmidt AJ, Pollock BH, et al
    The impact of COVID-19 vaccination on California's return to normalcy.
    PLoS One. 2022;17:e0264195.
    PubMed     Abstract available


  146. OSUJI VC, Galante EM, Mischoulon D, Slaven JE, et al
    COVID-19 vaccine: A 2021 analysis of perceptions on vaccine safety and promise in a U.S. sample.
    PLoS One. 2022;17:e0268784.
    PubMed     Abstract available


  147. BONNER KE, Ssekyanzi H, Sicsic J, Mueller JE, et al
    What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda.
    PLoS One. 2022;17:e0268063.
    PubMed     Abstract available


  148. WITUS LS, Larson E
    A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention.
    PLoS One. 2022;17:e0267580.
    PubMed     Abstract available


  149. GUZMAN-HOLST A, Luna-Casas G, Burguete Garcia A, Madrid-Marina V, et al
    Burden of disease and associated complications of hepatitis a in children and adults in Mexico: A retrospective database study.
    PLoS One. 2022;17:e0268469.
    PubMed     Abstract available


  150. ACKAH M, Ameyaw L, Gazali Salifu M, Afi Asubonteng DP, et al
    COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268711.
    PubMed     Abstract available


  151. IWAMOTO M, Ukimura A, Ogawa T, Kawanishi F, et al
    Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer's BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study.
    PLoS One. 2022;17:e0268529.
    PubMed     Abstract available


  152. EL DEEB O, Jalloul M
    Efficacy versus abundancy: Comparing vaccination schemes.
    PLoS One. 2022;17:e0267840.
    PubMed     Abstract available


  153. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    PubMed     Abstract available


  154. SEREDA AD, Kazakova AS, Dmitrenko VV, Kolbasov DV, et al
    Search for additional tests for immunobiological evaluation of the candidate vaccines against African swine fever.
    PLoS One. 2022;17:e0265819.
    PubMed     Abstract available


  155. MERMIN-BUNNELL K, Ahn WK
    It's Time to be disgusting about COVID-19: Effect of disgust priming on COVID-19 public health compliance among liberals and conservatives.
    PLoS One. 2022;17:e0267735.
    PubMed     Abstract available


  156. BUTLER JZ, Carson M, Rios-Fetchko F, Vargas R, et al
    COVID-19 vaccination readiness among multiple racial and ethnic groups in the San Francisco Bay Area: A qualitative analysis.
    PLoS One. 2022;17:e0266397.
    PubMed     Abstract available


  157. ASRI A, Asri V, Renerte B, Follmi-Heusi F, et al
    Which hospital workers do (not) want the jab? Behavioral correlates of COVID-19 vaccine willingness among employees of Swiss hospitals.
    PLoS One. 2022;17:e0268775.
    PubMed     Abstract available


  158. AHETO JMK, Pannell O, Dotse-Gborgbortsi W, Trimner MK, et al
    Multilevel analysis of predictors of multiple indicators of childhood vaccination in Nigeria.
    PLoS One. 2022;17:e0269066.
    PubMed     Abstract available


  159. SPRENGHOLZ P, Henkel L, Betsch C
    Payments and freedoms: Effects of monetary and legal incentives on COVID-19 vaccination intentions in Germany.
    PLoS One. 2022;17:e0268911.
    PubMed     Abstract available


  160. SILVA EKVB, Bomfim CG, Barbosa AP, Noda P, et al
    Immunization with SARS-CoV-2 Nucleocapsid protein triggers a pulmonary immune response in rats.
    PLoS One. 2022;17:e0268434.
    PubMed     Abstract available


  161. RAQIB R, Sarker P, Akhtar E, Nurul Huda TM, et al
    Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
    PLoS One. 2022;17:e0268093.
    PubMed     Abstract available


  162. NG JWJ, Vaithilingam S, Nair M, Hwang LA, et al
    Key predictors of COVID-19 vaccine hesitancy in Malaysia: An integrated framework.
    PLoS One. 2022;17:e0268926.
    PubMed     Abstract available


  163. NISHIMURA M, Sugawa S, Ota S, Suematsu E, et al
    Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.
    PLoS One. 2022;17:e0267566.
    PubMed     Abstract available


  164. AGHAMIR SMK, Khatami F, Farrokhpour H, Oliveira Reis L, et al
    Oncologic outcomes of Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis.
    PLoS One. 2022;17:e0267934.
    PubMed     Abstract available


  165. GEBRETNSAE H, Hadgu T, Ayele B, Gebre-Egziabher E, et al
    Knowledge of vaccine handlers and status of cold chain and vaccine management in primary health care facilities of Tigray region, Northern Ethiopia: Institutional based cross-sectional study.
    PLoS One. 2022;17:e0269183.
    PubMed     Abstract available


  166. ROGERS BG, Tao J, Almonte A, Toma E, et al
    Statewide evaluation of COVID-19 vaccine hesitancy in Rhode Island.
    PLoS One. 2022;17:e0268587.
    PubMed     Abstract available


  167. PILTCH-LOEB R, Silver DR, Kim Y, Norris H, et al
    Determinants of the COVID-19 vaccine hesitancy spectrum.
    PLoS One. 2022;17:e0267734.
    PubMed     Abstract available


  168. AHIAKPA JK, Cosmas NT, Anyiam FE, Enalume KO, et al
    COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans.
    PLoS One. 2022;17:e0268230.
    PubMed     Abstract available


  169. JOSHI A, Surapaneni KM, Kaur M, Bhatt A, et al
    A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    PLoS One. 2022;17:e0269299.
    PubMed     Abstract available


  170. PATRICK L, Bakeera-Kitaka S, Rujumba J, Malande OO, et al
    Encouraging improvement in HPV vaccination coverage among adolescent girls in Kampala, Uganda.
    PLoS One. 2022;17:e0269655.
    PubMed     Abstract available


  171. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available


  172. ERCHICK DJ, Gupta M, Blunt M, Bansal A, et al
    Understanding determinants of vaccine hesitancy and acceptance in India: A qualitative study of government officials and civil society stakeholders.
    PLoS One. 2022;17:e0269606.
    PubMed     Abstract available


  173. KHAIRKHAH N, Bolhassani A, Agi E, Namvar A, et al
    Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen.
    PLoS One. 2022;17:e0268251.
    PubMed     Abstract available


  174. BITZENHOFER M, Suter-Riniker F, Moor MB, Sidler D, et al
    Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.
    PLoS One. 2022;17:e0268780.
    PubMed     Abstract available


  175. DARKWA S, de Wildt G, Dalaba M, Vidzro E, et al
    "I would have to sell things in order to get the money": A qualitative exploration of willingness to pay for the RTS,S/AS01 malaria vaccine in the Volta region, Ghana.
    PLoS One. 2022;17:e0268009.
    PubMed     Abstract available


  176. VILLANUEVA P, Wadia U, Crawford NW, Messina NL, et al
    The safety of co-administration of Bacille Calmette-Guerin (BCG) and influenza vaccines.
    PLoS One. 2022;17:e0268042.
    PubMed     Abstract available


  177. MOSE A, Wasie A, Shitu S, Haile K, et al
    Determinants of COVID-19 vaccine acceptance in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0269273.
    PubMed     Abstract available


  178. DE ANDRADE PEREIRA SILVA M, Ribeiro HF, Oliveira RR, Pelloso FC, et al
    Factors associated with vaccination against Covid-19 in pregnant and hospitalized postpartum women: A retrospective cohort study.
    PLoS One. 2022;17:e0269091.
    PubMed     Abstract available


  179. BOHN-GOLDBAUM E, Owen KB, Lee VYJ, Booy R, et al
    Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis.
    PLoS One. 2022;17:e0268625.
    PubMed     Abstract available


  180. GU M, Taylor B, Pollack HA, Schneider JA, et al
    A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US.
    PLoS One. 2022;17:e0269320.
    PubMed     Abstract available


  181. RANI MDM, Mohamed NA, Solehan HM, Ithnin M, et al
    Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach.
    PLoS One. 2022;17:e0269059.
    PubMed     Abstract available


  182. PAPANEOPHYTOU C, Nicolaou A, Pieri M, Nicolaidou V, et al
    Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.
    PLoS One. 2022;17:e0269885.
    PubMed     Abstract available


  183. RANGELOVA V, Raycheva R, Sariyan S, Kevorkyan A, et al
    Reporting adverse events of COVID-19 vaccines: The case of Bulgaria.
    PLoS One. 2022;17:e0269727.
    PubMed     Abstract available


  184. KOBASHI Y, Shimazu Y, Kawamura T, Nishikawa Y, et al
    Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine.
    PLoS One. 2022;17:e0269917.
    PubMed     Abstract available


  185. PAWASKAR M, Fergie J, Harley C, Samant S, et al
    Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States.
    PLoS One. 2022;17:e0269916.
    PubMed     Abstract available


  186. MA Y, Zhao Y, Chen R, Sun W, et al
    Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
    PLoS One. 2022;17:e0269153.
    PubMed     Abstract available


  187. DESALEGN M, Garoma G, Tamrat H, Desta A, et al
    The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
    PLoS One. 2022;17:e0265140.
    PubMed     Abstract available


  188. CERVANTES-LUEVANO K, Espino-Vazquez AN, Flores-Acosta G, Bernaldez-Sarabia J, et al
    Neutralizing antibodies levels are increased in individuals with heterologous vaccination and hybrid immunity with Ad5-nCoV in the north of Mexico.
    PLoS One. 2022;17:e0269032.
    PubMed     Abstract available


  189. SIEWCHAISAKUL P, Sarakarn P, Nanthanangkul S, Longkul J, et al
    Role of literacy, fear and hesitancy on acceptance of COVID-19 vaccine among village health volunteers in Thailand.
    PLoS One. 2022;17:e0270023.
    PubMed     Abstract available


  190. MOONEY J, Price J, Bain C, Bawa JT, et al
    Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
    PLoS One. 2022;17:e0270369.
    PubMed     Abstract available


  191. LANIER HD, Diaz MI, Saleh SN, Lehmann CU, et al
    Analyzing COVID-19 disinformation on Twitter using the hashtags #scamdemic and #plandemic: Retrospective study.
    PLoS One. 2022;17:e0268409.
    PubMed     Abstract available


  192. BACURAU AGM, Sato APS, Francisco PMSB
    Correction: Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2022;17:e0270443.
    PubMed     Abstract available


  193. TAKEUCHI M, Esaki A, Higa Y, Nakazono A, et al
    Temporal changes in spike IgG levels after two doses of BNT162b2 vaccine in Japanese healthcare workers: Do spike IgG levels at 3 months predict levels 6 or 8 months after vaccination?
    PLoS One. 2022;17:e0263486.
    PubMed     Abstract available


  194. ACHENBACH CJ, Caputo M, Hawkins C, Balmert LC, et al
    Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.
    PLoS One. 2022;17:e0270060.
    PubMed     Abstract available


  195. ABAY ES, Belew MD, Ketsela BS, Mengistu EE, et al
    Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0269923.
    PubMed     Abstract available


  196. AWUNI JA, Ayamga M, Dagunga G
    Covid-19 vaccination intensions among literate Ghanaians: Still the need to dissipate fear and build trust on vaccine efficacy?
    PLoS One. 2022;17:e0270742.
    PubMed     Abstract available


  197. SAAD E, Sadiq S, Jamil R, Rustam F, et al
    Novel extreme regression-voting classifier to predict death risk in vaccinated people using VAERS data.
    PLoS One. 2022;17:e0270327.
    PubMed     Abstract available


  198. BURGER MN, Mayer M, Steimanis I
    Repeated information of benefits reduces COVID-19 vaccination hesitancy: Experimental evidence from Germany.
    PLoS One. 2022;17:e0270666.
    PubMed     Abstract available


  199. RAHMAN MM, Chisty MA, Alam MA, Sakib MS, et al
    Knowledge, attitude, and hesitancy towards COVID-19 vaccine among university students of Bangladesh.
    PLoS One. 2022;17:e0270684.
    PubMed     Abstract available


  200. AMOUR MA, Rees CA, Munseri PJ, Said J, et al
    Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    PLoS One. 2022;17:e0268685.
    PubMed     Abstract available


  201. FERGIE J, Pawaskar M, Veeranki P, Samant S, et al
    Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US.
    PLoS One. 2022;17:e0269596.
    PubMed     Abstract available


  202. ATSAWASUWAN P, Del Campo DM, Del Campo LM, Viana G, et al
    Positivity rates of SAR-CoV-2 infection in orthodontic patients at the orthodontic clinic, University of Illinois Chicago.
    PLoS One. 2022;17:e0270311.
    PubMed     Abstract available


    January 2021
  203. MITCHELL G, Leonard L, Carter G, Santin O, et al
    Evaluation of a 'serious game' on nursing student knowledge and uptake of influenza vaccination.
    PLoS One. 2021;16:e0245389.
    PubMed     Abstract available


  204. SONGANE M, Grossmann V
    The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.
    PLoS One. 2021;16:e0244722.
    PubMed     Abstract available


  205. KAINGA HW, Ssendagire S, Ssanyu JN, Nabukeera S, et al
    Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    PLoS One. 2021;16:e0243137.
    PubMed     Abstract available


  206. BARAL R, Levin A, Odero C, Pecenka C, et al
    Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0244995.
    PubMed     Abstract available


  207. MPOFU R, Otwombe K, Mlisana K, Nchabeleng M, et al
    Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
    PLoS One. 2021;16:e0241708.
    PubMed     Abstract available


  208. ATTWELL K, Lake J, Sneddon J, Gerrans P, et al
    Converting the maybes: Crucial for a successful COVID-19 vaccination strategy.
    PLoS One. 2021;16:e0245907.
    PubMed     Abstract available


  209. RODGERS LR, Streeter AJ, Lin N, Hamilton W, et al
    Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.
    PLoS One. 2021;16:e0246156.
    PubMed     Abstract available


  210. ARNOLD ME, Courcier EA, Stringer LA, McCormick CM, et al
    A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles).
    PLoS One. 2021;16:e0246141.
    PubMed     Abstract available


  211. PRAYITNO A, Supriyatno B, Munasir Z, Karuniawati A, et al
    Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study.
    PLoS One. 2021;16:e0245789.
    PubMed     Abstract available


  212. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in healthcare workers, Honduras.
    PLoS One. 2021;16:e0246379.
    PubMed     Abstract available


  213. SIMWAKA J, Seheri M, Mulundu G, Kaonga P, et al
    Rotavirus breakthrough infections responsible for gastroenteritis in vaccinated infants who presented with acute diarrhoea at University Teaching Hospitals, Children's Hospital in 2016, in Lusaka Zambia.
    PLoS One. 2021;16:e0246025.
    PubMed     Abstract available


  214. ASHFAQ UA, Saleem S, Masoud MS, Ahmad M, et al
    Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approach.
    PLoS One. 2021;16:e0245072.
    PubMed     Abstract available


  215. LOPEZ MORENO G, Nirmala J, Goodell C, Culhane M, et al
    Shedding and transmission of a live attenuated influenza A virus vaccine in pre-weaned pigs under field conditions.
    PLoS One. 2021;16:e0246690.
    PubMed     Abstract available


  216. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination in postpartum women, Honduras.
    PLoS One. 2021;16:e0246385.
    PubMed     Abstract available


  217. MADEWELL ZJ, Chacon-Fuentes R, Jara J, Mejia-Santos H, et al
    Knowledge, attitudes, and practices of seasonal influenza vaccination among older adults in nursing homes and daycare centers, Honduras.
    PLoS One. 2021;16:e0246382.
    PubMed     Abstract available


  218. VANNI T, Thome BDC, Oliveira MMM, Gattas VL, et al
    Active pharmacovigilance of the seasonal trivalent influenza vaccine produced by Instituto Butantan: A prospective cohort study of five target groups.
    PLoS One. 2021;16:e0246540.
    PubMed     Abstract available


  219. GOUGLAS D, Marsh K
    Prioritizing investments in rapid response vaccine technologies for emerging infections: A portfolio decision analysis.
    PLoS One. 2021;16:e0246235.
    PubMed     Abstract available


  220. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand.
    PLoS One. 2021;16:e0245894.
    PubMed     Abstract available


  221. CHANIE MG, Ewunetie GE, Molla A, Muche A, et al
    Determinants of vaccination dropout among children 12-23 months age in north Gondar zone, northwest Ethiopia, 2019.
    PLoS One. 2021;16:e0246018.
    PubMed     Abstract available


  222. LATKIN CA, Dayton L, Yi G, Colon B, et al
    Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US.
    PLoS One. 2021;16:e0246970.
    PubMed     Abstract available


  223. LEE J, Yoon Y, Kim EJ, Lee D, et al
    23-valent polysaccharide vaccine (PPSV23)-targeted serotype-specific identification of Streptococcus pneumoniae using the loop-mediated isothermal amplification (LAMP) method.
    PLoS One. 2021;16:e0246699.
    PubMed     Abstract available


  224. KOZAKOVA J, Krizova P, Maly M
    Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    PLoS One. 2021;16:e0247862.
    PubMed     Abstract available


  225. WAGAI JN, Rhoda D, Prier M, Trimmer MK, et al
    Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0247415.
    PubMed     Abstract available


  226. MOHAMMED SA, Workneh BD, Kahissay MH
    Knowledge, attitude and practice of vaccinators and vaccine handlers on vaccine cold chain management in public health facilities, Ethiopia: Cross-sectional study.
    PLoS One. 2021;16:e0247459.
    PubMed     Abstract available


  227. FORGACS D, Abreu RB, Sautto GA, Kirchenbaum GA, et al
    Convergent antibody evolution and clonotype expansion following influenza virus vaccination.
    PLoS One. 2021;16:e0247253.
    PubMed     Abstract available


  228. MATTER D, Potgieter L
    Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    PLoS One. 2021;16:e0248053.
    PubMed     Abstract available


  229. XU Z, Wu B, Topcu U
    Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach.
    PLoS One. 2021;16:e0247660.
    PubMed     Abstract available


  230. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    PubMed     Abstract available


  231. BOKHARAIE VS
    A study on the effects of containment policies and vaccination on the spread of SARS-CoV-2.
    PLoS One. 2021;16:e0247439.
    PubMed     Abstract available


  232. GERMANI F, Biller-Andorno N
    The anti-vaccination infodemic on social media: A behavioral analysis.
    PLoS One. 2021;16:e0247642.
    PubMed     Abstract available


  233. KARDANI K, Bolhassani A
    Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    PLoS One. 2021;16:e0247396.
    PubMed     Abstract available


  234. DE LUSIGNAN S, Hoang U, Liyanage H, Tripathy M, et al
    Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network.
    PLoS One. 2021;16:e0248123.
    PubMed     Abstract available


  235. JANG H, Ross TM
    Hemagglutination Inhibition (HAI) antibody landscapes after vaccination with H7Nx virus like particles.
    PLoS One. 2021;16:e0246613.
    PubMed     Abstract available


  236. OTIANG E, Thumbi SM, Campbell ZA, Njagi LW, et al
    Impact of routine Newcastle disease vaccination on chicken flock size in smallholder farms in western Kenya.
    PLoS One. 2021;16:e0248596.
    PubMed     Abstract available


  237. CHUKWUDOZIE OS, Gray CM, Fagbayi TA, Chukwuanukwu RC, et al
    Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    PLoS One. 2021;16:e0248061.
    PubMed     Abstract available


  238. SHINJOH M, Sugaya N, Yamaguchi Y, Ookawara I, et al
    Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
    PLoS One. 2021;16:e0249005.
    PubMed     Abstract available


  239. KURU O, Stecula D, Lu H, Ophir Y, et al
    The effects of scientific messages and narratives about vaccination.
    PLoS One. 2021;16:e0248328.
    PubMed     Abstract available


  240. EDWARDS B, Biddle N, Gray M, Sollis K, et al
    COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    PLoS One. 2021;16:e0248892.
    PubMed     Abstract available


  241. PROMPETCHARA E, Ketloy C, Tharakhet K, Kaewpang P, et al
    DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in mice.
    PLoS One. 2021;16:e0248007.
    PubMed     Abstract available


  242. KONDO KUNIEDA M, Manzo ML, Shibanuma A, Jimba M, et al
    Rapidly modifiable factors associated with full vaccination status among children in Niamey, Niger: A cross-sectional, random cluster household survey.
    PLoS One. 2021;16:e0249026.
    PubMed     Abstract available


  243. ACACIO S, Nhampossa T, Quinto L, Vubil D, et al
    Rotavirus disease burden pre-vaccine introduction in young children in Rural Southern Mozambique, an area of high HIV prevalence.
    PLoS One. 2021;16:e0249714.
    PubMed     Abstract available


  244. EYTHORSSON E, Asgeirsdottir TL, Erlendsdottir H, Hrafnkelsson B, et al
    The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.
    PLoS One. 2021;16:e0249497.
    PubMed     Abstract available


  245. STUURMAN AL, Rizzo C, Haag M
    Investigating the procurement system for understanding seasonal influenza vaccine brand availability in Europe.
    PLoS One. 2021;16:e0248943.
    PubMed     Abstract available


  246. ACEVEDO-VILLANUEVA K, Renu S, Gourapura R, Selvaraj R, et al
    Efficacy of a nanoparticle vaccine administered in-ovo against Salmonella in broilers.
    PLoS One. 2021;16:e0247938.
    PubMed     Abstract available


  247. RAZA MT, Mizan S, Yasmin F, Akash AS, et al
    Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
    PLoS One. 2021;16:e0248001.
    PubMed     Abstract available


  248. RIOS-BLANCAS MJ, Lamadrid-Figueroa H, Betancourt-Cravioto M, Lozano R, et al
    Vaccination coverage estimation in Mexico in children under five years old: Trends and associated factors.
    PLoS One. 2021;16:e0250172.
    PubMed     Abstract available


  249. FRIDMAN A, Gershon R, Gneezy A
    COVID-19 and vaccine hesitancy: A longitudinal study.
    PLoS One. 2021;16:e0250123.
    PubMed     Abstract available


  250. ASSEN AM, Walkden-Brown SW, Stillman M, Alfirevich S, et al
    Comparison of tracheal and choanal cleft swabs and poultry dust samples for detection of Newcastle disease virus and infectious bronchitis virus genome in vaccinated meat chicken flocks.
    PLoS One. 2021;16:e0247729.
    PubMed     Abstract available


  251. OYO-ITA A, Bosch-Capblanch X, Ross A, Oku A, et al
    Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    PLoS One. 2021;16:e0248236.
    PubMed     Abstract available



  252. Expression of Concern: Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones.
    PLoS One. 2021;16:e0250485.
    PubMed    


  253. GONCALVES P, Saez-Lopez E, Carneiro S, Simoes MJ, et al
    Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme.
    PLoS One. 2021;16:e0250103.
    PubMed     Abstract available


  254. NJUMA LIBWEA J, A Fletcher M, Koki Ndombo P, Boula A, et al
    Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0250010.
    PubMed     Abstract available


  255. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    PubMed     Abstract available


  256. EL-ELIMAT T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, et al
    Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan.
    PLoS One. 2021;16:e0250555.
    PubMed     Abstract available


  257. BARAL R, Levin A, Odero C, Pecenka C, et al
    Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
    PLoS One. 2021;16:e0250863.
    PubMed     Abstract available


  258. ADIL MAHMOUD YOUSIF N, Tsoungui Obama HCJ, Ngucho Mbeutchou YJ, Kwamou Ngaha SF, et al
    The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement.
    PLoS One. 2021;16:e0245417.
    PubMed     Abstract available


  259. COUDEVILLE L, Jollivet O, Mahe C, Chaves S, et al
    Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study.
    PLoS One. 2021;16:e0250797.
    PubMed     Abstract available


  260. ABEDIN M, Islam MA, Rahman FN, Reza HM, et al
    Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.
    PLoS One. 2021;16:e0250495.
    PubMed     Abstract available


  261. QIN W, Wang E, Ni Z
    Chinese consumers' willingness to get a COVID-19 vaccine and willingness to pay for it.
    PLoS One. 2021;16:e0250112.
    PubMed     Abstract available


  262. KARUNARATNE ND, Newkirk RW, Ames NP, Van Kessel AG, et al
    Effects of exogenous beta-glucanase on ileal digesta soluble beta-glucan molecular weight, digestive tract characteristics, and performance of coccidiosis vaccinated broiler chickens fed hulless barley-based diets with and without medication.
    PLoS One. 2021;16:e0236231.
    PubMed     Abstract available


  263. BAUM U, Kulathinal S, Auranen K
    Exposure misclassification bias in the estimation of vaccine effectiveness.
    PLoS One. 2021;16:e0251622.
    PubMed     Abstract available


  264. WOLFF E, Widgren K, Scalia Tomba G, Roth A, et al
    Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    PLoS One. 2021;16:e0251644.
    PubMed     Abstract available


  265. YOUNG LS, Danial Z
    Three pre-vaccine responses to Covid-like epidemics.
    PLoS One. 2021;16:e0251349.
    PubMed     Abstract available


  266. ISLAM MS, Kamal AM, Kabir A, Southern DL, et al
    COVID-19 vaccine rumors and conspiracy theories: The need for cognitive inoculation against misinformation to improve vaccine adherence.
    PLoS One. 2021;16:e0251605.
    PubMed     Abstract available


  267. PILTCH-LOEB R, Savoia E, Goldberg B, Hughes B, et al
    Examining the effect of information channel on COVID-19 vaccine acceptance.
    PLoS One. 2021;16:e0251095.
    PubMed     Abstract available


  268. GRAEBER D, Schmidt-Petri C, Schroder C
    Attitudes on voluntary and mandatory vaccination against COVID-19: Evidence from Germany.
    PLoS One. 2021;16:e0248372.
    PubMed     Abstract available


  269. SANO K, Saito S, Suzuki T, Kotani O, et al
    An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody.
    PLoS One. 2021;16:e0245244.
    PubMed     Abstract available


  270. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    PubMed     Abstract available


  271. ELIZONDO-ALZOLA U, G Carrasco M, Pinos L, Picchio CA, et al
    Vaccine hesitancy among paediatric nurses: Prevalence and associated factors.
    PLoS One. 2021;16:e0251735.
    PubMed     Abstract available


  272. LEVINE G, Salifu A, Mohammed I, Fink G, et al
    Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana.
    PLoS One. 2021;16:e0247485.
    PubMed     Abstract available


  273. ATUHAIRE DK, Muleya W, Mbao V, Niyongabo J, et al
    Molecular characterization and population genetics of Theileria parva in Burundi's unvaccinated cattle: Towards the introduction of East Coast fever vaccine.
    PLoS One. 2021;16:e0251500.
    PubMed     Abstract available


  274. CAINI S, Paget J, Spreeuwenberg P, Korevaar JC, et al
    Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees.
    PLoS One. 2021;16:e0249883.
    PubMed     Abstract available


  275. EZAJ MMA, Haque MS, Syed SB, Khan MSA, et al
    Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.
    PLoS One. 2021;16:e0252295.
    PubMed     Abstract available


  276. ZEIGLER DF, Gage E, Clegg CH
    Epitope-targeting platform for broadly protective influenza vaccines.
    PLoS One. 2021;16:e0252170.
    PubMed     Abstract available


  277. KITONSA J, Kamacooko O, Bahemuka UM, Kibengo F, et al
    Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda.
    PLoS One. 2021;16:e0251992.
    PubMed     Abstract available


  278. CHE X, Liu Y, Wang J, Xu Y, et al
    Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
    PLoS One. 2021;16:e0251567.
    PubMed     Abstract available


  279. NIKOLOVSKI J, Koldijk M, Weverling GJ, Spertus J, et al
    Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults.
    PLoS One. 2021;16:e0251963.
    PubMed     Abstract available


  280. NAKPHOOK S, Patumanond J, Shrestha M, Prasert K, et al
    Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.
    PLoS One. 2021;16:e0253028.
    PubMed     Abstract available


  281. KHOU C, Diaz-Salinas MA, da Costa A, Prehaud C, et al
    Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
    PLoS One. 2021;16:e0252595.
    PubMed     Abstract available


  282. KAHANA D, Yamin D
    Accounting for the spread of vaccination behavior to optimize influenza vaccination programs.
    PLoS One. 2021;16:e0252510.
    PubMed     Abstract available


  283. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0252332.
    PubMed     Abstract available


  284. WOLDU HG, Zalwango S, Martinez L, Castellanos ME, et al
    Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda.
    PLoS One. 2021;16:e0245328.
    PubMed     Abstract available


  285. STUURMAN AL, Ciampini S, Vannacci A, Bella A, et al
    Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.
    PLoS One. 2021;16:e0252836.
    PubMed     Abstract available


  286. STRODEL R, Dayton L, Garrison-Desany HM, Eber G, et al
    COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans.
    PLoS One. 2021;16:e0253208.
    PubMed     Abstract available


  287. LINKS IJ, Denholm LJ, Evers M, Kingham LJ, et al
    Is vaccination a viable method to control Johne's disease caused by Mycobacterium avium subsp. paratuberculosis? Data from 12 million ovine vaccinations and 7.6 million carcass examinations in New South Wales, Australia from 1999-2009.
    PLoS One. 2021;16:e0246411.
    PubMed     Abstract available


  288. PALMER EA, Penagaricano F, Vedovatto M, Oliveira RA, et al
    Effects of maternal gestational diet, with or without methionine, on muscle transcriptome of Bos indicus-influenced beef calves following a vaccine-induced immunological challenge.
    PLoS One. 2021;16:e0253810.
    PubMed     Abstract available


  289. RIVIERE C, Bell T, Cadot Y, Perodin C, et al
    Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti.
    PLoS One. 2021;16:e0252310.
    PubMed     Abstract available


  290. HANDEBO S, Wolde M, Shitu K, Kassie A, et al
    Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia.
    PLoS One. 2021;16:e0253499.
    PubMed     Abstract available


  291. WARIRI O, Okomo U, Kwarshak YK, Murray KA, et al
    Timeliness of routine childhood vaccination in low- and middle-income countries, 1978-2021: Protocol for a scoping review to map methodologic gaps and determinants.
    PLoS One. 2021;16:e0253423.
    PubMed     Abstract available


  292. WAGAI JN, Rhoda DA, Prier ML, Trimner MK, et al
    Correction: Implementing WHO guidance on conducting and analysing vaccination coverage cluster surveys: Two examples from Nigeria.
    PLoS One. 2021;16:e0253670.
    PubMed     Abstract available


  293. KHAN MT, Islam R, Jerin TJ, Mahmud A, et al
    Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.
    PLoS One. 2021;16:e0253393.
    PubMed     Abstract available


  294. TUNGGAL HC, Munson PV, O'Connor MA, Hajari N, et al
    Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs.
    PLoS One. 2021;16:e0253265.
    PubMed     Abstract available


  295. WISNEWSKI AV, Campillo Luna J, Redlich CA
    Human IgG and IgA responses to COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0249499.
    PubMed     Abstract available


  296. SPARGO RM, Coetzer A, Makuvadze FT, Chikerema SM, et al
    Knowledge, attitudes and practices towards rabies: A survey of the general population residing in the Harare Metropolitan Province of Zimbabwe.
    PLoS One. 2021;16:e0246103.
    PubMed     Abstract available


  297. MCKUNE S, Serra R, Toure A
    Gender and intersectional analysis of livestock vaccine value chains in Kaffrine, Senegal.
    PLoS One. 2021;16:e0252045.
    PubMed     Abstract available


  298. RUJUMBA J, Akugizibwe M, Basta NE, Banura C, et al
    Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.
    PLoS One. 2021;16:e0253735.
    PubMed     Abstract available


  299. THANEE C, Kittikraisak W, Sinthuwattanawibool C, Roekworachai K, et al
    Knowledge, attitude/perception, and practice related to seasonal influenza vaccination among caregivers of young Thai children: A cross-sectional study.
    PLoS One. 2021;16:e0253561.
    PubMed     Abstract available


  300. DUTTA T, Agley J, Meyerson BE, Barnes PA, et al
    Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis.
    PLoS One. 2021;16:e0253318.
    PubMed     Abstract available



  301. Correction: Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children <5 years in Cameroon, 2011-2018.
    PLoS One. 2021;16:e0254616.
    PubMed     Abstract available


  302. AJOVALASIT S, Dorgali VM, Mazza A, d'Onofrio A, et al
    Evidence of disorientation towards immunization on online social media after contrasting political communication on vaccines. Results from an analysis of Twitter data in Italy.
    PLoS One. 2021;16:e0253569.
    PubMed     Abstract available


  303. PAWASKAR M, Burgess C, Pillsbury M, Wisloff T, et al
    Clinical and economic impact of universal varicella vaccination in Norway: A modeling study.
    PLoS One. 2021;16:e0254080.
    PubMed     Abstract available


  304. DAVAHLI MR, Karwowski W, Fiok K
    Optimizing COVID-19 vaccine distribution across the United States using deterministic and stochastic recurrent neural networks.
    PLoS One. 2021;16:e0253925.
    PubMed     Abstract available


  305. YASSI A, Grant JM, Lockhart K, Barker S, et al
    Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    PLoS One. 2021;16:e0254920.
    PubMed     Abstract available


  306. STODDARD M, Sarkar S, Yuan L, Nolan RP, et al
    Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
    PLoS One. 2021;16:e0254734.
    PubMed     Abstract available


  307. LU M, Ishwaran H
    Cure and death play a role in understanding dynamics for COVID-19: Data-driven competing risk compartmental models, with and without vaccination.
    PLoS One. 2021;16:e0254397.
    PubMed     Abstract available


  308. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
    The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
    PLoS One. 2021;16:e0254456.
    PubMed     Abstract available


  309. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    PubMed     Abstract available


  310. KOLLI SK, Salman AM, Ramesar J, Chevalley-Maurel S, et al
    Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
    PLoS One. 2021;16:e0254498.
    PubMed     Abstract available


  311. INOUE K, Kashima S
    Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19.
    PLoS One. 2021;16:e0253169.
    PubMed     Abstract available


  312. DUTTA S, Kumar A, Dutta M, Walsh C, et al
    Retraction: Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    PLoS One. 2021;16:e0255347.
    PubMed    


  313. DITOSTO JD, Weiss RE, Yee LM, Badreldin N, et al
    Association of Tdap vaccine guidelines with vaccine uptake during pregnancy.
    PLoS One. 2021;16:e0254863.
    PubMed     Abstract available


  314. ALVAREZ MM, Bravo-Gonzalez S, Trujillo-de Santiago G
    Modeling vaccination strategies in an Excel spreadsheet: Increasing the rate of vaccination is more effective than increasing the vaccination coverage for containing COVID-19.
    PLoS One. 2021;16:e0254430.
    PubMed     Abstract available


  315. KUHN R, Henwood B, Lawton A, Kleva M, et al
    COVID-19 vaccine access and attitudes among people experiencing homelessness from pilot mobile phone survey in Los Angeles, CA.
    PLoS One. 2021;16:e0255246.
    PubMed     Abstract available


  316. DEPELSENAIRE ACI, Witham K, Veitch M, Wells JW, et al
    Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial.
    PLoS One. 2021;16:e0255282.
    PubMed     Abstract available


  317. SCORDO JM, Aguillon-Duran GP, Ayala D, Quirino-Cerrillo AP, et al
    A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor.
    PLoS One. 2021;16:e0255194.
    PubMed     Abstract available


  318. CLAVE LLAVALL A, de Wildt G, Meza G, Tattsbridge J, et al
    Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV) vaccination program in Iquitos, Peru: A qualitative study.
    PLoS One. 2021;16:e0255218.
    PubMed     Abstract available


  319. JOSHUA PE, Nwauzor CO, Odimegwu DC, Ukachukwu UG, et al
    Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice.
    PLoS One. 2021;16:e0246915.
    PubMed     Abstract available


  320. CHISSAQUE A, Bauhofer AFL, Cossa-Moiane I, Sitoe E, et al
    Rotavirus A infection in pre- and post-vaccine period: Risk factors, genotypes distribution by vaccination status and age of children in Nampula Province, Northern Mozambique (2015-2019).
    PLoS One. 2021;16:e0255720.
    PubMed     Abstract available


  321. ABREU RB, Kirchenbaum GA, Sautto GA, Clutter EF, et al
    Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination.
    PLoS One. 2021;16:e0254421.
    PubMed     Abstract available


  322. MANT M, Aslemand A, Prine A, Jaagumagi Holland A, et al
    University students' perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study.
    PLoS One. 2021;16:e0255447.
    PubMed     Abstract available


  323. TAGHIOFF SM, Slavin BR, Holton T, Singh D, et al
    Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients.
    PLoS One. 2021;16:e0255541.
    PubMed     Abstract available


  324. CARCAMO DE LA CONCEPCION M, Sargent DJ, Surbanovski N, Colgan RJ, et al
    De novo sequencing and analysis of the transcriptome of two highbush blueberry (Vaccinium corymbosum L.) cultivars 'Bluecrop' and 'Legacy' at harvest and following post-harvest storage.
    PLoS One. 2021;16:e0255139.
    PubMed     Abstract available


  325. ALDOSSRI M, Okoronkwo C, Dodd V, Manson H, et al
    Determinants of dentists' readiness to assess HPV risk and recommend immunization: A transtheoretical model of change-based cross-sectional study of Ontario dentists.
    PLoS One. 2021;16:e0247043.
    PubMed     Abstract available


  326. KUMAR S, Purakayastha DR, Kapil A, Saha S, et al
    Carriage rates and antimicrobial sensitivity of pneumococci in the upper respiratory tract of children less than ten years old, in a north Indian rural community.
    PLoS One. 2021;16:e0246522.
    PubMed     Abstract available


  327. MOHAMED NA, Solehan HM, Mohd Rani MD, Ithnin M, et al
    Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey.
    PLoS One. 2021;16:e0256110.
    PubMed     Abstract available


  328. GONZALEZ-BLOCK MA, Pelcastre-Villafuerte BE, Riva Knauth D, Fachel-Leal A, et al
    Influenza vaccination hesitancy in large urban centers in South America. Qualitative analysis of confidence, complacency and convenience across risk groups.
    PLoS One. 2021;16:e0256040.
    PubMed     Abstract available


  329. MAGEE K, Marsh IR, Turek MM, Grudzinski J, et al
    Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
    PLoS One. 2021;16:e0255798.
    PubMed     Abstract available


  330. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0255382.
    PubMed     Abstract available


  331. ZHAO X, Tatapudi H, Corey G, Gopalappa C, et al
    Threshold analyses on combinations of testing, population size, and vaccine coverage for COVID-19 control in a university setting.
    PLoS One. 2021;16:e0255864.
    PubMed     Abstract available


  332. PAUL A, Sikdar D, Mahanta J, Ghosh S, et al
    Peoples' understanding, acceptance, and perceived challenges of vaccination against COVID-19: A cross-sectional study in Bangladesh.
    PLoS One. 2021;16:e0256493.
    PubMed     Abstract available


  333. ESHUN-WILSON I, Mody A, Tram KH, Bradley C, et al
    Preferences for COVID-19 vaccine distribution strategies in the US: A discrete choice survey.
    PLoS One. 2021;16:e0256394.
    PubMed     Abstract available


  334. MOTTA M, Stecula D
    Quantifying the effect of Wakefield et al. (1998) on skepticism about MMR vaccine safety in the U.S.
    PLoS One. 2021;16:e0256395.
    PubMed     Abstract available


  335. HU W, DeMarcus LS, Sjoberg PA, Robbins AS, et al
    Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    PLoS One. 2021;16:e0256165.
    PubMed     Abstract available


  336. HOPKER A, Pandey N, Bartholomew R, Blanton A, et al
    Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam.
    PLoS One. 2021;16:e0256684.
    PubMed     Abstract available


  337. FATIREGUN AA, Lochlainn LN, Kabore L, Dosumu M, et al
    Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
    PLoS One. 2021;16:e0252798.
    PubMed     Abstract available


  338. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    PubMed     Abstract available


  339. ABD ELHAFEEZ S, Elbarazi I, Shaaban R, ElMakhzangy R, et al
    Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents.
    PLoS One. 2021;16:e0254595.
    PubMed     Abstract available


  340. TRAVIS J, Harris S, Fadel T, Webb G, et al
    Identifying the determinants of COVID-19 preventative behaviors and vaccine intentions among South Carolina residents.
    PLoS One. 2021;16:e0256178.
    PubMed     Abstract available


  341. KRICORIAN K, Turner K
    COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans.
    PLoS One. 2021;16:e0256122.
    PubMed     Abstract available


  342. KALAM MA, Davis TP Jr, Shano S, Uddin MN, et al
    Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    PLoS One. 2021;16:e0256496.
    PubMed     Abstract available


  343. ALI RN, Rubin H, Sarkar S
    Countering the potential re-emergence of a deadly infectious disease-Information warfare, identifying strategic threats, launching countermeasures.
    PLoS One. 2021;16:e0256014.
    PubMed     Abstract available


  344. SALING LL, Mallal D, Scholer F, Skelton R, et al
    No one is immune to misinformation: An investigation of misinformation sharing by subscribers to a fact-checking newsletter.
    PLoS One. 2021;16:e0255702.
    PubMed     Abstract available


  345. ANGELO AT, Alemayehu DS, Dachew AM
    Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021.
    PLoS One. 2021;16:e0257109.
    PubMed     Abstract available


  346. SUNOHARA S, Asakura T, Kimura T, Ozawa S, et al
    Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan.
    PLoS One. 2021;16:e0257107.
    PubMed     Abstract available


  347. KULKARNI R, Chen WC, Lee Y, Kao CF, et al
    Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
    PLoS One. 2021;16:e0257191.
    PubMed     Abstract available


  348. MAHMUD S, Mohsin M, Khan IA, Mian AU, et al
    Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.
    PLoS One. 2021;16:e0257096.
    PubMed     Abstract available


  349. WISNEWSKI AV, Redlich CA, Liu J, Kamath K, et al
    Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0252849.
    PubMed     Abstract available


  350. PEREZ-ARCE F, Angrisani M, Bennett D, Darling J, et al
    COVID-19 vaccines and mental distress.
    PLoS One. 2021;16:e0256406.
    PubMed     Abstract available


  351. SKLAR MJ, Maiolatesi S, Patterson N, Sedegah M, et al
    A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naive adults.
    PLoS One. 2021;16:e0256980.
    PubMed     Abstract available


  352. MALIK A, Malik J, Ishaq U
    Acceptance of COVID-19 vaccine in Pakistan among health care workers.
    PLoS One. 2021;16:e0257237.
    PubMed     Abstract available


  353. DERUELLE P, Couffignal C, Sibiude J, Vivanti AJ, et al
    Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
    PLoS One. 2021;16:e0256080.
    PubMed     Abstract available


  354. LIMOTHAI U, Tachaboon S, Dinhuzen J, Hunsawong T, et al
    Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area.
    PLoS One. 2021;16:e0257182.
    PubMed     Abstract available


  355. MENA G, Blanco B, Casas I, Huertas A, et al
    Attitudes of Spanish hospital staff towards COVID-19 vaccination and vaccination rates.
    PLoS One. 2021;16:e0257002.
    PubMed     Abstract available


  356. PRAVEEN C, Bhatia SS, Alaniz RC, Droleskey RE, et al
    Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium.
    PLoS One. 2021;16:e0243417.
    PubMed     Abstract available


  357. PENNEY MD, Yargic Y, Smolin L, Thommes EW, et al
    "Hot-spotting" to improve vaccine allocation by harnessing digital contact tracing technology: An application of percolation theory.
    PLoS One. 2021;16:e0256889.
    PubMed     Abstract available


  358. HAILE K, Timerga A, Mose A, Mekonnen Z, et al
    Hepatitis B vaccination status and associated factors among students of medicine and health sciences in Wolkite University, Southwest Ethiopia: A cross-sectional study.
    PLoS One. 2021;16:e0257621.
    PubMed     Abstract available


  359. TAKEUCHI M, Higa Y, Esaki A, Nabeshima Y, et al
    Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?
    PLoS One. 2021;16:e0257668.
    PubMed     Abstract available


  360. KYPRIANIDOU M, Tzira E, Galanis P, Giannakou K, et al
    Knowledge of mothers regarding children's vaccinations in Cyprus: A cross-sectional study.
    PLoS One. 2021;16:e0257590.
    PubMed     Abstract available


  361. FUKUDA Y, Ando S, Fukuda K
    Knowledge and preventive actions toward COVID-19, vaccination intent, and health literacy among educators in Japan: An online survey.
    PLoS One. 2021;16:e0257552.
    PubMed     Abstract available


  362. MARQUEZ C, Kerkhoff AD, Naso J, Contreras MG, et al
    A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice.
    PLoS One. 2021;16:e0257111.
    PubMed     Abstract available


  363. QUAYE T, Narkwa PW, Domfeh SA, Kattah G, et al
    Immunosurveillance and molecular detection of hepatitis B virus infection amongst vaccinated children in the West Gonja District in Savanna Region of Ghana.
    PLoS One. 2021;16:e0257103.
    PubMed     Abstract available


  364. PIERACCI EG, Williams CE, Wallace RM, Kalapura CR, et al
    U.S. dog importations during the COVID-19 pandemic: Do we have an erupting problem?
    PLoS One. 2021;16:e0254287.
    PubMed     Abstract available


  365. NGCAMPHALALA C, Ostensson E, Ginindza TG
    The economic burden of cervical cancer in Eswatini: Societal perspective.
    PLoS One. 2021;16:e0250113.
    PubMed     Abstract available


  366. KIM MH, Son NH, Park YS, Lee JH, et al
    Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects.
    PLoS One. 2021;16:e0258236.
    PubMed     Abstract available


  367. ROBERTSON CT, Bentele K, Meyerson B, Wood ASA, et al
    Effects of political versus expert messaging on vaccination intentions of Trump voters.
    PLoS One. 2021;16:e0257988.
    PubMed     Abstract available


  368. BACHELET T, Bourdenx JP, Martinez C, Mucha S, et al
    Humoral response after SARS-CoV-2 mRNA vaccines in dialysis patients: Integrating anti-SARS-CoV-2 Spike-Protein-RBD antibody monitoring to manage dialysis centers in pandemic times.
    PLoS One. 2021;16:e0257646.
    PubMed     Abstract available


  369. MURAYAMA T, Shimizu N, Fujita S, Wakamiya S, et al
    Predicting regional influenza epidemics with uncertainty estimation using commuting data in Japan.
    PLoS One. 2021;16:e0250417.
    PubMed     Abstract available


  370. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    PubMed     Abstract available


  371. ZAKHOUR R, Tamim H, Faytrouni F, Khoury J, et al
    Knowledge, attitude and practice of influenza vaccination among Lebanese parents: A cross-sectional survey from a developing country.
    PLoS One. 2021;16:e0258258.
    PubMed     Abstract available


  372. WHELAN J, Marshall H, Sullivan TR
    Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.
    PLoS One. 2021;16:e0254330.
    PubMed     Abstract available


  373. NAVASCUES M, Budroni C, Guryanova Y
    Disease control as an optimization problem.
    PLoS One. 2021;16:e0257958.
    PubMed     Abstract available


  374. BALDWIN SL, Reese VA, Larsen SE, Beebe E, et al
    Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
    PLoS One. 2021;16:e0247990.
    PubMed     Abstract available


  375. ROUBY SR, Safwat NM, Hussein KH, Abdel-Ra'ouf AM, et al
    Lumpy skin disease outbreaks in Egypt during 2017-2018 among sheeppox vaccinated cattle: Epidemiological, pathological, and molecular findings.
    PLoS One. 2021;16:e0258755.
    PubMed     Abstract available


  376. WIN TTZ, Campbell A, Magalhaes RJS, Oo KN, et al
    What drives small-scale farmers to vaccinate their multiple livestock species animals against common infectious diseases in Myanmar?
    PLoS One. 2021;16:e0258765.
    PubMed     Abstract available


  377. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed     Abstract available


  378. MALAMBA SS, Muyinda H, Ogwang DM, Katamba A, et al
    Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda.
    PLoS One. 2021;16:e0251573.
    PubMed     Abstract available


  379. KURTZ SL, De Pascalis R, Meierovics AI, Elkins KL, et al
    Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    PLoS One. 2021;16:e0249142.
    PubMed     Abstract available


  380. COHEN AA, Yang Z, Gnanapragasam PNP, Ou S, et al
    Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers.
    PLoS One. 2021;16:e0247963.
    PubMed     Abstract available


  381. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed     Abstract available


  382. ARGOTE TIRONI P, Barham E, Zuckerman Daly S, Gerez JE, et al
    Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    PLoS One. 2021;16:e0259059.
    PubMed     Abstract available


  383. GAO X, Wang L, Zhang H, Zhu B, et al
    Transcriptome analysis and identification of genes associated with floral transition and fruit development in rabbiteye blueberry (Vaccinium ashei).
    PLoS One. 2021;16:e0259119.
    PubMed     Abstract available


  384. ELLIOTT T, Yehia BR, Winegar AL, Raja JK, et al
    Analysis of COVID-19 vaccine non-intent by essential vs non-essential worker, demographic, and socioeconomic status among 101,048 US adults.
    PLoS One. 2021;16:e0258540.
    PubMed     Abstract available


  385. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available


  386. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed     Abstract available


  387. TARIQ MH, Bhatti R, Ali NF, Ashfaq UA, et al
    Rational design of chimeric Multiepitope Based Vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach.
    PLoS One. 2021;16:e0258443.
    PubMed     Abstract available


  388. JANG H, Ross TM
    Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    PLoS One. 2021;16:e0258453.
    PubMed     Abstract available


  389. ENRIA L, Bangura JS, Kanu HM, Kalokoh JA, et al
    Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
    PLoS One. 2021;16:e0258252.
    PubMed     Abstract available


  390. SOWE A, Njie M, Sowe D, Fofana S, et al
    Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    PLoS One. 2021;16:e0258961.
    PubMed     Abstract available


  391. ARNHEIM-DAHLSTROM L, Zarabi N, Hagen K, Bencina G, et al
    Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study.
    PLoS One. 2021;16:e0256642.
    PubMed     Abstract available


  392. GOMES D, Beyerlein A, Katz K, Hoelscher G, et al
    Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.
    PLoS One. 2021;16:e0259370.
    PubMed     Abstract available


  393. SCHNEIDER JA, Taylor BG, Hotton AL, Lamuda PA, et al
    National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out.
    PLoS One. 2021;16:e0259257.
    PubMed     Abstract available


  394. HYLAND P, Vallieres F, Hartman TK, McKay R, et al
    Detecting and describing stability and change in COVID-19 vaccine receptibility in the United Kingdom and Ireland.
    PLoS One. 2021;16:e0258871.
    PubMed     Abstract available


  395. FANTIN RF, Fraga VG, Lopes CA, de Azevedo IC, et al
    New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.
    PLoS One. 2021;16:e0258637.
    PubMed     Abstract available


  396. DOHERTY IA, Pilkington W, Brown L, Billings V, et al
    COVID-19 vaccine hesitancy in underserved communities of North Carolina.
    PLoS One. 2021;16:e0248542.
    PubMed     Abstract available


  397. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed     Abstract available


  398. PRENTOE J, Janitzek CM, Velazquez-Moctezuma R, Goksoyr L, et al
    Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
    PLoS One. 2021;16:e0255336.
    PubMed     Abstract available


  399. MUELLER JE, Seanehia J, Yaro S, Trotter CL, et al
    Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns.
    PLoS One. 2021;16:e0253263.
    PubMed     Abstract available


  400. BONAPARTE SC, Adams L, Bakamutumaho B, Barbosa Costa G, et al
    Rabies post-exposure healthcare-seeking behaviors and perceptions: Results from a knowledge, attitudes, and practices survey, Uganda, 2013.
    PLoS One. 2021;16:e0251702.
    PubMed     Abstract available


  401. KUMAR NP, Padmapriyadarsini C, Rajamanickam A, Bhavani PK, et al
    BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gammac cytokines in elderly individuals.
    PLoS One. 2021;16:e0258743.
    PubMed     Abstract available


  402. WISMANS A, Thurik R, Baptista R, Dejardin M, et al
    Correction: Psychological characteristics and the mediating role of the 5C Model in explaining students' COVID-19 vaccination intention.
    PLoS One. 2021;16:e0259922.
    PubMed     Abstract available


  403. HEINE F, Wolters E
    Using moral foundations in government communication to reduce vaccine hesitancy.
    PLoS One. 2021;16:e0259435.
    PubMed     Abstract available


  404. GRAY AN, Martin-Blais R, Tobin NH, Wang Y, et al
    Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection.
    PLoS One. 2021;16:e0259703.
    PubMed     Abstract available


  405. GOMES DE MACEDO BACURAU A, Sato APS, Francisco PMSB
    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed     Abstract available


  406. KISAKA S, Makumbi FE, Majalija S, Kagaha A, et al
    "As long as the patient tells you it was a dog that bit him, why do you need to know more?" A qualitative study of how healthcare workers apply clinical guidelines to treat dog bite injuries in selected hospitals in Uganda.
    PLoS One. 2021;16:e0254650.
    PubMed     Abstract available


  407. MBULAWA ZZA, Somdyala NI, Mabunda SA, Williamson AL, et al
    High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa.
    PLoS One. 2021;16:e0253074.
    PubMed     Abstract available


  408. STOCKELER AM, Schuster P, Zimmermann M, Hanses F, et al
    Influenza vaccination coverage among emergency department personnel is associated with perception of vaccination and side effects, vaccination availability on site and the COVID-19 pandemic.
    PLoS One. 2021;16:e0260213.
    PubMed     Abstract available


  409. KIKUTI M, Sanhueza J, Vilalta C, Paploski IAD, et al
    Porcine reproductive and respiratory syndrome virus 2 (PRRSV-2) genetic diversity and occurrence of wild type and vaccine-like strains in the United States swine industry.
    PLoS One. 2021;16:e0259531.
    PubMed     Abstract available


  410. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed     Abstract available


  411. VENKATESAN MM, Ballou C, Barnoy S, McNeal M, et al
    Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding.
    PLoS One. 2021;16:e0259361.
    PubMed     Abstract available


  412. BAUM U, Poukka E, Palmu AA, Salo H, et al
    Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.
    PLoS One. 2021;16:e0258704.
    PubMed     Abstract available


  413. ISLAM MR, Oraby T, McCombs A, Chowdhury MM, et al
    Evaluation of the United States COVID-19 vaccine allocation strategy.
    PLoS One. 2021;16:e0259700.
    PubMed     Abstract available


  414. BRESLIN G, Dempster M, Berry E, Cavanagh M, et al
    COVID-19 vaccine uptake and hesitancy survey in Northern Ireland and Republic of Ireland: Applying the theory of planned behaviour.
    PLoS One. 2021;16:e0259381.
    PubMed     Abstract available


  415. GERRETSEN P, Kim J, Caravaggio F, Quilty L, et al
    Individual determinants of COVID-19 vaccine hesitancy.
    PLoS One. 2021;16:e0258462.
    PubMed     Abstract available


  416. SCHERRER JF, Salas J, Wiemken TL, Hoft DF, et al
    Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts.
    PLoS One. 2021;16:e0257405.
    PubMed     Abstract available


  417. PAPAZOGLOU DD, Baretella O, Feller M, Del Giovane C, et al
    Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients.
    PLoS One. 2021;16:e0260112.
    PubMed     Abstract available


  418. SCHOMMER SK, Harrison N, Linville M, Samuel MS, et al
    Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance.
    PLoS One. 2021;16:e0260052.
    PubMed     Abstract available


  419. ACEVEDO-VILLANUEVA KY, Renu S, Shanmugasundaram R, Akerele GO, et al
    Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds.
    PLoS One. 2021;16:e0259334.
    PubMed     Abstract available


  420. BRADFIELD Z, Wynter K, Hauck Y, Sweet L, et al
    COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia.
    PLoS One. 2021;16:e0260049.
    PubMed     Abstract available


  421. SINCLAIR DR, Maharani A, Stow D, Welsh CE, et al
    Can vaccination roll-out be more equitable if population risk is taken into account?
    PLoS One. 2021;16:e0259990.
    PubMed     Abstract available


  422. MUHAJARINE N, Adeyinka DA, McCutcheon J, Green KL, et al
    COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    PLoS One. 2021;16:e0259513.
    PubMed     Abstract available


  423. COOKSON D, Jolley D, Dempsey RC, Povey R, et al
    A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents.
    PLoS One. 2021;16:e0258985.
    PubMed     Abstract available


  424. RAO CY, Robinson T, Huster K, Laws RL, et al
    Occupational exposures and mitigation strategies among homeless shelter workers at risk of COVID-19.
    PLoS One. 2021;16:e0253108.
    PubMed     Abstract available


  425. GOMES LC, Sanson MCG, Brainin P, de Melo MDCV, et al
    Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon.
    PLoS One. 2021;16:e0253752.
    PubMed     Abstract available


  426. JEREMIAH K, Lyimo E, Ritz C, PrayGod G, et al
    Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    PLoS One. 2021;16:e0252808.
    PubMed     Abstract available


  427. VAN EGEREN D, Stoddard M, Novokhodko A, Rogers MS, et al
    Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.
    PLoS One. 2021;16:e0258997.
    PubMed     Abstract available


  428. CHACON-DIAZ C, Zabalza-Barangua A, San Roman B, Blasco JM, et al
    Brucella abortus S19 GFP-tagged vaccine allows the serological identification of vaccinated cattle.
    PLoS One. 2021;16:e0260288.
    PubMed     Abstract available


  429. DEVI YD, Goswami HB, Konwar S, Doley C, et al
    Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
    PLoS One. 2021;16:e0258645.
    PubMed     Abstract available


  430. YAMAMOTO K, Suzuki M, Ujiie M, Kanagawa S, et al
    Catch-up immunization for adolescents and young adults during pre-travel consultation in Japan.
    PLoS One. 2021;16:e0258357.
    PubMed     Abstract available


  431. ZORIGT T, Furuta Y, Simbotwe M, Ochi A, et al
    Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
    PLoS One. 2021;16:e0258317.
    PubMed     Abstract available


  432. PHATIHATTAKORN C, Wongsa A, Pongpan K, Anuwuthinawin S, et al
    Seroprevalence of Zika virus in pregnant women from central Thailand.
    PLoS One. 2021;16:e0257205.
    PubMed     Abstract available


  433. LUCHEN CC, Mwaba J, Ng'ombe H, Alabi PIO, et al
    Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.
    PLoS One. 2021;16:e0260552.
    PubMed     Abstract available


  434. MENA G, Casas I, Casan C, Aunon M, et al
    Influenza vaccination coverage and factors associated with severe laboratory-confirmed influenza-related illness in patients receiving care at a tertiary hospital in Catalonia (Spain) during the 2018-2019 epidemic season.
    PLoS One. 2021;16:e0260397.
    PubMed     Abstract available


  435. CAPITINE IPU, Macicame IB, Uanela AM, Bhatt NB, et al
    Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
    PLoS One. 2021;16:e0260126.
    PubMed     Abstract available


  436. ANJORIN AA, Odetokun IA, Abioye AI, Elnadi H, et al
    Will Africans take COVID-19 vaccination?
    PLoS One. 2021;16:e0260575.
    PubMed     Abstract available


  437. BRAILOVSKAIA J, Schneider S, Margraf J
    To vaccinate or not to vaccinate!? Predictors of willingness to receive Covid-19 vaccination in Europe, the U.S., and China.
    PLoS One. 2021;16:e0260230.
    PubMed     Abstract available


  438. IOANNOU GN, Green P, Locke ER, Berry K, et al
    Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system.
    PLoS One. 2021;16:e0259696.
    PubMed     Abstract available


  439. GUPTA S, Watanabe S, Laurent SM
    Psychological predictors of vaccination intentions among U.S. undergraduates and online panel workers during the 2020 COVID-19 pandemic.
    PLoS One. 2021;16:e0260380.
    PubMed     Abstract available


  440. MUSTAPHA M, Lawal BK, Sha'aban A, Jatau AI, et al
    Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria.
    PLoS One. 2021;16:e0260672.
    PubMed     Abstract available


  441. ABDOU MS, Kheirallah KA, Aly MO, Ramadan A, et al
    The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries.
    PLoS One. 2021;16:e0260321.
    PubMed     Abstract available


  442. DROPPA-ALMEIDA D, da Silva GA, Gaspar LMDAC, Pereyra BBS, et al
    Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
    PLoS One. 2021;16:e0256864.
    PubMed     Abstract available


  443. BARRY M, Temsah MH, Alhuzaimi A, Alamro N, et al
    COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation.
    PLoS One. 2021;16:e0244415.
    PubMed     Abstract available


  444. POLLOCK BH, Kilpatrick AM, Eisenman DP, Elton KL, et al
    Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020.
    PLoS One. 2021;16:e0258738.
    PubMed     Abstract available


  445. GALLANT AJ, Nicholls LAB, Rasmussen S, Cogan N, et al
    Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    PLoS One. 2021;16:e0261844.
    PubMed     Abstract available


  446. QAMAR W, Qayum M, Sadiq N
    Assessing the knowledge and skill of vaccination staff at Adult Vaccination Counters for COVID-19 vaccines: Simulated client method.
    PLoS One. 2021;16:e0261286.
    PubMed     Abstract available


  447. FONTENOT HB, Mattheus DB, Lim E, Michel A, et al
    Undergraduate nursing students' COVID-19 vaccine intentions: A national survey.
    PLoS One. 2021;16:e0261669.
    PubMed     Abstract available


  448. MAYAN D, Nguyen K, Keisler B
    National attitudes of medical students towards mandating the COVID-19 vaccine and its association with knowledge of the vaccine.
    PLoS One. 2021;16:e0260898.
    PubMed     Abstract available


  449. YANG C, Yang Y, Li Y
    Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    PLoS One. 2021;16:e0261236.
    PubMed     Abstract available


  450. KING WC, Rubinstein M, Reinhart A, Mejia R, et al
    Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021.
    PLoS One. 2021;16:e0260731.
    PubMed     Abstract available


  451. SUBEDI P, Yadav GK, Paudel B, Regmi A, et al
    Adverse events following the first dose of Covishield (ChAdOx1 nCoV-19) vaccination among health workers in selected districts of central and western Nepal: A cross-sectional study.
    PLoS One. 2021;16:e0260638.
    PubMed     Abstract available


  452. FIRSTOVA VV, Shakhova AS, Riabko AK, Silkina MV, et al
    Characterization of the adaptive immune response of donors receiving live anthrax vaccine.
    PLoS One. 2021;16:e0260202.
    PubMed     Abstract available


  453. ROSETTIE KL, Joffe JN, Sparks GW, Aravkin A, et al
    Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
    PLoS One. 2021;16:e0260808.
    PubMed     Abstract available


  454. MOHAMMED R, Nguse TM, Habte BM, Fentie AM, et al
    COVID-19 vaccine hesitancy among Ethiopian healthcare workers.
    PLoS One. 2021;16:e0261125.
    PubMed     Abstract available


  455. HORIUCHI S, Sakamoto H, Abe SK, Shinohara R, et al
    Factors of parental COVID-19 vaccine hesitancy: A cross sectional study in Japan.
    PLoS One. 2021;16:e0261121.
    PubMed     Abstract available


  456. THOMPSON J, Wattam S
    Estimating the impact of interventions against COVID-19: From lockdown to vaccination.
    PLoS One. 2021;16:e0261330.
    PubMed     Abstract available



  457. Retraction: Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and Long-Term-siRNA Treatment.
    PLoS One. 2021;16:e0261693.
    PubMed    


  458. KOESNOE S, Masjkuri N, Adisasmita A, Djauzi S, et al
    A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
    PLoS One. 2021;16:e0250234.
    PubMed     Abstract available


  459. ZENS KD, Baroutsou V, Sinniger P, Lang P, et al
    A cross-sectional study evaluating tick-borne encephalitis vaccine uptake and timeliness among adults in Switzerland.
    PLoS One. 2021;16:e0247216.
    PubMed     Abstract available


  460. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    PubMed     Abstract available


  461. CASAS-DEZA D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, et al
    Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes.
    PLoS One. 2021;16:e0261061.
    PubMed     Abstract available


  462. HOSSAIN MB, Alam MZ, Islam MS, Sultan S, et al
    COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.
    PLoS One. 2021;16:e0260821.
    PubMed     Abstract available


  463. FERWANA I, Varshney LR
    Social capital dimensions are differentially associated with COVID-19 vaccinations, masks, and physical distancing.
    PLoS One. 2021;16:e0260818.
    PubMed     Abstract available


  464. HARGREAVES HEAP SP, Koop C, Matakos K, Unan A, et al
    Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement.
    PLoS One. 2021;16:e0260216.
    PubMed     Abstract available


  465. KADELKA C, McCombs A
    Effect of homophily and correlation of beliefs on COVID-19 and general infectious disease outbreaks.
    PLoS One. 2021;16:e0260973.
    PubMed     Abstract available


  466. GLAZIK R, Moore H, Kennedy D, Bower H, et al
    A snapshot of the practicality and barriers to COVID-19 interventions: Public health and healthcare workers' perceptions in high and low- and middle-income countries.
    PLoS One. 2021;16:e0260041.
    PubMed     Abstract available


  467. MUSTAFA SS, Jamshed S, Vadamalai K, Ramsey A, et al
    Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    PLoS One. 2021;16:e0258529.
    PubMed     Abstract available


  468. OYO-ITA AE, Hanlon P, Nwankwo O, Bosch-Capblanch X, et al
    Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    PLoS One. 2021;16:e0257277.
    PubMed     Abstract available


  469. AHSAN A, Dar S, Hassan F, Ghafoor F, et al
    Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus.
    PLoS One. 2021;16:e0256816.
    PubMed     Abstract available


  470. MACIUSZEK J, Polak M, Stasiuk K, Dolinski D, et al
    Active pro-vaccine and anti-vaccine groups: Their group identities and attitudes toward science.
    PLoS One. 2021;16:e0261648.
    PubMed     Abstract available


  471. JENSEN EA, Wagoner B, Pfleger A, Herbig L, et al
    Making sense of unfamiliar COVID-19 vaccines: How national origin affects vaccination willingness.
    PLoS One. 2021;16:e0261273.
    PubMed     Abstract available


  472. MIRON VD, Banica L, Sandulescu O, Paraschiv S, et al
    Clinical and molecular epidemiology of influenza viruses from Romanian patients hospitalized during the 2019/20 season.
    PLoS One. 2021;16:e0258798.
    PubMed     Abstract available


  473. LEE MF, Chiang CH, Lin SJ, Wu CS, et al
    Effectiveness and safety of oral lactococci-based vaccine encoding triple common allergens to prevent airway allergy in mice.
    PLoS One. 2021;16:e0261333.
    PubMed     Abstract available


  474. BERENDAM SJ, Morgan-Asiedu PK, Mangan RJ, Li SH, et al
    Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques.
    PLoS One. 2021;16:e0256885.
    PubMed     Abstract available


  475. PEREZ CHACON G, Fathima P, Jones M, Barnes R, et al
    Pertussis immunisation in infancy and atopic outcomes: A protocol for a population-based cohort study using linked administrative data.
    PLoS One. 2021;16:e0260388.
    PubMed     Abstract available


  476. VEALS AM, Koprowski JL, Bergman DL, VerCauteren KC, et al
    Occurrence of mesocarnivores in montane sky islands: How spatial and temporal overlap informs rabies management in a regional hotspot.
    PLoS One. 2021;16:e0259260.
    PubMed     Abstract available


  477. GUAN TH, Htut HN, Davison CM, Sebastian S, et al
    Implementation of a neonatal hepatitis B immunization program in rural Karenni State, Myanmar: A mixed-methods study.
    PLoS One. 2021;16:e0261470.
    PubMed     Abstract available


    January 2020
  478. SWAIN JK, Carpio Y, Johansen LH, Velazquez J, et al
    Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.).
    PLoS One. 2020;15:e0239827.
    PubMed     Abstract available


  479. JEMBERU WT, Molla W, Dagnew T, Rushton J, et al
    Farmers' willingness to pay for foot and mouth disease vaccine in different cattle production systems in Amhara region of Ethiopia.
    PLoS One. 2020;15:e0239829.
    PubMed     Abstract available


  480. BUDU E, Darteh EKM, Ahinkorah BO, Seidu AA, et al
    Trend and determinants of complete vaccination coverage among children aged 12-23 months in Ghana: Analysis of data from the 1998 to 2014 Ghana Demographic and Health Surveys.
    PLoS One. 2020;15:e0239754.
    PubMed     Abstract available


  481. KAMEI K, Miyairi I, Ishikura K, Ogura M, et al
    Prospective study of live attenuated vaccines for patients receiving immunosuppressive agents.
    PLoS One. 2020;15:e0240217.
    PubMed     Abstract available


  482. SCHMITT-VAN DE LEEMPUT E, Metcalfe LVA, Caldow G, Walz PH, et al
    Comparison of milk production of dairy cows vaccinated with a live double deleted BVDV vaccine and non-vaccinated dairy cows cohabitating in commercial herds endemically infected with BVD virus.
    PLoS One. 2020;15:e0240113.
    PubMed     Abstract available


  483. VADLAMUDI NK, Patrick DM, Hoang L, Sadarangani M, et al
    Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
    PLoS One. 2020;15:e0239848.
    PubMed     Abstract available


  484. CHUNG GS, Hutton DW
    Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.
    PLoS One. 2020;15:e0239926.
    PubMed     Abstract available


  485. NOWAK SA, Chen C, Parker AM, Gidengil CA, et al
    Comparing covariation among vaccine hesitancy and broader beliefs within Twitter and survey data.
    PLoS One. 2020;15:e0239826.
    PubMed     Abstract available


  486. HUGHES HE, Elliot AJ, Hughes TC, Hungerford D, et al
    Using emergency department syndromic surveillance to investigate the impact of a national vaccination program: A retrospective observational study.
    PLoS One. 2020;15:e0240021.
    PubMed     Abstract available


  487. KUMAR A, Misra S, Verma V, Vishwakarma RK, et al
    Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19.
    PLoS One. 2020;15:e0240710.
    PubMed     Abstract available


  488. HUON JF, Gregoire A, Meireles A, Lefebvre M, et al
    Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    PLoS One. 2020;15:e0234693.
    PubMed     Abstract available


  489. LI J, Yu W, Zhao Z, Zhang L, et al
    Measles vaccination among children in border areas of Yunnan Province, Southwest China.
    PLoS One. 2020;15:e0240733.
    PubMed     Abstract available


  490. FOIS A, Boucher-Lafleur AM, Thompson Legault J, Renaud C, et al
    Humoral responses to the measles, mumps and rubella vaccine are impaired in Leigh Syndrome French Canadian patients.
    PLoS One. 2020;15:e0239860.
    PubMed     Abstract available


  491. BONNEVIE E, Rosenberg SD, Kummeth C, Goldbarg J, et al
    Using social media influencers to increase knowledge and positive attitudes toward the flu vaccine.
    PLoS One. 2020;15:e0240828.
    PubMed     Abstract available


  492. AGYEI-BAFFOUR P, Asare M, Lanning B, Koranteng A, et al
    Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model.
    PLoS One. 2020;15:e0240657.
    PubMed     Abstract available


  493. DEGAREGE A, Krupp K, Srinivas V, Ibrahimou B, et al
    Structural equation modeling to detect correlates of childhood vaccination: A moderated mediation analysis.
    PLoS One. 2020;15:e0240749.
    PubMed     Abstract available


  494. COHEN ND, Cywes-Bentley C, Kahn SM, Bordin AI, et al
    Vaccination of yearling horses against poly-N-acetyl glucosamine fails to protect against infection with Streptococcus equi subspecies equi.
    PLoS One. 2020;15:e0240479.
    PubMed     Abstract available


  495. KHAIRKHAH N, Aghasadeghi MR, Namvar A, Bolhassani A, et al
    Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis.
    PLoS One. 2020;15:e0240577.
    PubMed     Abstract available


  496. ANDERSON MS, Niemuth NA, Sabourin CL, Badorrek CS, et al
    Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
    PLoS One. 2020;15:e0238196.
    PubMed     Abstract available


  497. TSAI MH, Liao SL, Chiu CY, Shih HJ, et al
    Longitudinal investigation of nasopharyngeal pneumococcal carriage in early childhood: The PATCH birth cohort study.
    PLoS One. 2020;15:e0237871.
    PubMed     Abstract available


  498. KANDEIL A, Gomaa MR, El Taweel A, Mostafa A, et al
    Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
    PLoS One. 2020;15:e0241471.
    PubMed     Abstract available


  499. AWOKE N, Mulgeta H, Lolaso T, Tekalign T, et al
    Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0241226.
    PubMed     Abstract available


  500. SZIGETI R, Kellermayer D, Trakimas G, Kellermayer R, et al
    BCG epidemiology supports its protection against COVID-19? A word of caution.
    PLoS One. 2020;15:e0240203.
    PubMed     Abstract available


  501. NOEL G, Badmasti F, Nikbin VS, Zahraei SM, et al
    Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    PLoS One. 2020;15:e0238398.
    PubMed     Abstract available


  502. GURNANI V, Singh P, Haldar P, Aggarwal MK, et al
    Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).
    PLoS One. 2020;15:e0241369.
    PubMed     Abstract available


  503. VILCHES TN, Shoukat A, Ferreira CP, Moghadas SM, et al
    Projecting influenza vaccine effectiveness: A simulation study.
    PLoS One. 2020;15:e0241549.
    PubMed     Abstract available


  504. WHITE ER, Hebert-Dufresne L
    State-level variation of initial COVID-19 dynamics in the United States.
    PLoS One. 2020;15:e0240648.
    PubMed     Abstract available


  505. ARAUJO LO, Nunes AMPB, Ferreira VM, Cardoso CW, et al
    Clinical and epidemiological features of pertussis in Salvador, Brazil, 2011-2016.
    PLoS One. 2020;15:e0238932.
    PubMed     Abstract available


  506. DE MUNTER AC, Ruijs WLM, Ruiter RAC, van Nimwegen DJJ, et al
    Decision-making on maternal pertussis vaccination among women in a vaccine-hesitant religious group: Stages and needs.
    PLoS One. 2020;15:e0242261.
    PubMed     Abstract available


  507. GOMES JM, Silva BM, Santos EFS, Kelly PJ, et al
    Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance.
    PLoS One. 2020;15:e0241674.
    PubMed     Abstract available


  508. SHAHZAMAL M, Mans B, Hoog F, Paini D, et al
    Vaccination strategies on dynamic networks with indirect transmission links and limited contact information.
    PLoS One. 2020;15:e0241612.
    PubMed     Abstract available


  509. CARANNANTE A, Fazio C, Neri A, Lista F, et al
    Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.
    PLoS One. 2020;15:e0241793.
    PubMed     Abstract available


  510. KAZIMBAYA KM, Chisenga CC, Simuyandi M, Phiri CM, et al
    In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
    PLoS One. 2020;15:e0240714.
    PubMed     Abstract available


  511. VEZINA B, Petit GA, Martin JL, Halili MA, et al
    Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets.
    PLoS One. 2020;15:e0241306.
    PubMed     Abstract available


  512. CASPE SG, Livingstone M, Frew D, Aitchison K, et al
    The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection.
    PLoS One. 2020;15:e0242526.
    PubMed     Abstract available


  513. SHRESTHA DB, Khadka M, Khadka M, Subedi P, et al
    Hepatitis B vaccination status and knowledge, attitude, and practice regarding Hepatitis B among preclinical medical students of a medical college in Nepal.
    PLoS One. 2020;15:e0242658.
    PubMed     Abstract available


  514. BAYU H, Elias B, Abdisa S, Tune A, et al
    Post exposure prophylaxis coverage, vertical transmission and associated factors among hepatitis B exposed newborns delivered at Arsi zone health institutions, 2019.
    PLoS One. 2020;15:e0238987.
    PubMed     Abstract available


  515. HAVLICEK DF, Rosenberg JB, De BP, Hicks MJ, et al
    Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
    PLoS One. 2020;15:e0239780.
    PubMed     Abstract available


  516. GONZALEZ-BLOCK MA, Gutierrez-Calderon E, Pelcastre-Villafuerte BE, Arroyo-Laguna J, et al
    Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates.
    PLoS One. 2020;15:e0243833.
    PubMed     Abstract available


  517. WHANG YH, Kim SK, Yoon H, Choi SK, et al
    Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.
    PLoS One. 2020;15:e0243909.
    PubMed     Abstract available


  518. LUCIDARME J, Zhu B, Xu L, Bai X, et al
    Genomic analysis of the meningococcal ST-4821 complex-Western clade, potential sexual transmission and predicted antibiotic susceptibility and vaccine coverage.
    PLoS One. 2020;15:e0243426.
    PubMed     Abstract available


  519. KAJUNGU D, Muhoozi M, Stark J, Weibel D, et al
    Vaccines safety and maternal knowledge for enhanced maternal immunization acceptability in rural Uganda: A qualitative study approach.
    PLoS One. 2020;15:e0243834.
    PubMed     Abstract available


  520. NAGHIBI L, Yazdani M, Momtazi-Borojeni AA, Razazan A, et al
    Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.
    PLoS One. 2020;15:e0243550.
    PubMed     Abstract available



  521. Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    PLoS One. 2020;15:e0244011.
    PubMed    


  522. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Timeliness of immunisation with the pentavalent vaccine at different levels of the health care system in the Lao People's Democratic Republic: A cross-sectional study.
    PLoS One. 2020;15:e0242502.
    PubMed     Abstract available


  523. VEGA-POLO P, Cobo MM, Argudo A, Gutierrez B, et al
    Characterizing the genetic diversity of the Andean blueberry (Vaccinium floribundum Kunth.) across the Ecuadorian Highlands.
    PLoS One. 2020;15:e0243420.
    PubMed     Abstract available


  524. CHIMOYI L, Velen K, Churchyard GJ, Wallis R, et al
    An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
    PLoS One. 2020;15:e0243707.
    PubMed     Abstract available



  525. Retraction: Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
    PLoS One. 2020;15:e0244074.
    PubMed    


  526. CARCELEN AC, Hayford K, Moss WJ, Book C, et al
    How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.
    PLoS One. 2020;15:e0240734.
    PubMed     Abstract available


  527. TAHIR UL QAMAR M, Rehman A, Tusleem K, Ashfaq UA, et al
    Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    PLoS One. 2020;15:e0244176.
    PubMed     Abstract available


  528. AJIBOLA G, Bennett K, Powis KM, Hughes MD, et al
    Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    PLoS One. 2020;15:e0244100.
    PubMed     Abstract available


  529. DE LEMOS APS, Sacchi CT, Goncalves CR, Camargo CH, et al
    Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
    PLoS One. 2020;15:e0243375.
    PubMed     Abstract available


  530. FUDOLIG M, Howard R
    The local stability of a modified multi-strain SIR model for emerging viral strains.
    PLoS One. 2020;15:e0243408.
    PubMed     Abstract available


  531. JIANG W, Pilkington EH, Kelly HG, Tan HX, et al
    Aggregation by peptide conjugation rescues poor immunogenicity of the HA stem.
    PLoS One. 2020;15:e0241649.
    PubMed     Abstract available


  532. BELL S, Clarke R, Paterson P, Mounier-Jack S, et al
    Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England.
    PLoS One. 2020;15:e0244049.
    PubMed     Abstract available


  533. BERRY DA, Berry S, Hale P, Isakov L, et al
    A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
    PLoS One. 2020;15:e0244418.
    PubMed     Abstract available


  534. BOZIO CH, Isenhour C, McNamara LA
    Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States.
    PLoS One. 2020;15:e0241989.
    PubMed     Abstract available


  535. DO PC, Nguyen TH, Vo UHM, Le L, et al
    iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus.
    PLoS One. 2020;15:e0239112.
    PubMed     Abstract available


  536. TALAAT KR, Porter CK, Jaep KM, Duplessis CA, et al
    Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
    PLoS One. 2020;15:e0239888.
    PubMed     Abstract available


  537. MENIKOU S, McArdle AJ, Li MS, Kaforou M, et al
    A proteomics-based method for identifying antigens within immune complexes.
    PLoS One. 2020;15:e0244157.
    PubMed     Abstract available


  538. MUWONGE R, Basu P, Gheit T, Anantharaman D, et al
    Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.
    PLoS One. 2020;15:e0244242.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: